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The use of online Canadian pharmacies has grown over the past decade due to lower cost
medications and ease of use. In order for these firms to gain business and marketing
information, they collect a variety of consumer data. This has raised concerns among
consumers as to privacy issues of the data collected by these online firms. However,
researchers have not effectively examined how online consumers value specific privacy
factors when deciding whether to use the sites. Also, studies have not determined if many
of these sites have comprehensive privacy policies that indicate if they protect
consumers’ data for a variety of factors. This research included a study of 25 major
online Canadian pharmacies to determine the completeness of privacy policy factors
among this population. This survey showed the majority of sites did contain a privacy
policy. However, the comprehensiveness of policies differed vastly among the sites. This
dissertation also included an investigation of consumers’ views of the privacy policy
factors they feel are important when deciding to use these pharmacy sites. Results of a
survey of 147 users of medical Web sites showed that consumers were concerned about
privacy on these sites, with opt-in, security and consumer/licensing issues of high
importance. However, the study also showed that for consumers who actually used an
online pharmacy during the past year, cost savings, rather than privacy issues were the
principal concern. This dissertation created an instrument that online firms can use to
evaluate consumers perceptions of privacy policies, as well as which policies are
important to include on a Web site.
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1Chapter 1
Introduction
In a decade, consumer pharmaceutical sales have evolved from solely a brick-and-
mortar business to one involving the ability to order prescriptions via Internet-based
firms. Part of this industry also involves the rise of so-called “Canadian pharmacies” --
Web sites that offer American consumers the ability to purchase pharmaceuticals shipped
from Canada, usually at substantially reduced prices compared to prescriptions obtained
through traditional U.S. pharmacies.
Online businesses have gathered a rich amount of data about their customers for
marketing purposes and this growth of information has allowed the firms to better target
their audience and marketing efforts to gain new clientele. However, it has also created
concerns among online consumers who are apprehensive with the amount of data
collected, especially without their consent (Rose, 2000). This apprehension extends to
consumers in the online pharmacy realm. The increasing use of online pharmacy sites and
other commercial sales have necessitated governments adopting privacy laws, as well as
individual sites adopting comprehensive policies to protect consumer information. An
industry research firm, PharmacyChecker.com (2003a), notes that there is currently
inadequate protection of online consumers and that in 2003, 70% of the online American
and Canadian pharmacies did not provide adequate security and privacy of a customer's
personal and financial information.
This dissertation research evaluated the effectiveness of privacy protection among
various online Canadian pharmacy Web sites. Because of the rise in consumer awareness
2of privacy issues as well as the increase in Americans utilizing Canadian pharmacies, it is
helpful for consumers to understand which sites are meeting legal requirements and
industry guidelines for posted privacy statements. This study also examined other factors
that played a role in consumers’ usage of these sites, such as if they viewed licenses,
security features, and data sharing in a positive or negative light.
Problem Statement
Some Canadian online pharmacies may not meet American or Canadian privacy
laws and may not provide adequate privacy protection to their clientele. Non-adherence
to regulation or lack of consistent policies among the myriad of online pharmacy sites can
result in lack of secure private consumer information, consumer confusion about drug
information, and the possibility of third party organizations’ purchase of consumers’ data.
For those sites with policies, a key question asked was if the main elements in their
policies are stated in such a way that they effectively adhere to legal requirements and
address consumers’ privacy concerns.
Goal
An investigation of 25 major online Canadian pharmacies (see Appendix A)
determined how well these sites support industry guidelines. It was important to
understand how well the average site follows privacy guidelines, as this can affect
consumers’ perceptions and usage of a specific site. In addition, the research included a
survey of Canadian online pharmacy users and reviewed their experiences and attitudes
towards conducting purchases on these sites to determine if privacy issues are a major
concern.
3There were four facets to this study. The first was developing a framework of
analysis to determine if the sites adhered to legal privacy regulations. The second part
was analyzing statistical differences in privacy policies among 25 major online Canadian
pharmacy sites among the hundreds available on the Web. Third, the study determined
the comprehensiveness of privacy policies for Canadian online pharmacies. A pharmacy
site that scored well on the statistics gathered in the study can be considered highly
effective in promoting customer privacy and adhering to privacy laws and guidelines.
Finally, consumer views towards the use of these sites were analyzed to determine if
privacy issues were a major concern when conducting business on these pharmacy sites.
The product of this study is a model that can be used to evaluate the effectiveness of
privacy policies, not only for Canadian pharmacies, but perhaps also for a myriad of other
online, e-commerce firms.
Twenty-five online pharmacies provided an adequate sample to analyze privacy
policy issues. The researcher chose the 25 pharmacies from an online search of
Google.com. In addition to an analysis of these sites, a survey of 147 users of several
medical sites was conducted. A link to an online research questionnaire was posted on
several consumer medical information sites in order to assess consumer purchasing
patterns and viewpoints.
Research Questions
In this study of the use of privacy policies among Canadian online pharmacies,
the following research questions were addressed:
1. What types of privacy issues do Canadian online pharmacies address?
42. Do gaps exist in privacy protection provided to consumers of online Canadian
pharmacies?
3. Which online pharmacies offer the most comprehensive privacy policies and
what are their strengths and weaknesses?
4. What privacy and non-privacy criteria do consumers use when deciding to
order from these sites, and what factors do non-buyers cite for not purchasing
drugs?
Relevance and Significance
Relevance
The research in this area is relevant for several reasons. There has been a lack of
scholarly study addressing the issue of privacy policies among Canadian online
pharmacies. Several research papers have analyzed the results of studies performed on a
number of general Web sites with posted privacy policies, but none has accomplished an
in-depth review of only online Canadian pharmaceutical firms. A U.S. Federal Trade
Commission (FTC) study of American sites found that although 99% of general sites
collected personal information in 2000, only 20% of a random sample and 42% of the
most popular sites routinely observed fair information practices (overall guidelines to
which firms should adhere when conducting business) (“Online Privacy,” 2000). A more
recent study based on the FTC’s methodology was conducted in December 2001. The
researchers analyzed 85 of the busiest Web sites and found that sites were collecting less
information in 2001 than in prior years. They also found that fewer Web sites were
utilizing third party cookies, privacy notices were more prevalent and complete, and more
sites offered opt-in rather than opt-out options (Adkinson, Eisenach, & Lenard, 2002).
5There is a lack of comprehensive empirical research examining privacy issues as
they relate to online Canadian firms. PharmacyChecker.com (2003a) completed a study
of 20 online Canadian pharmacies. They based their study on the first 20 Canadian online
firms found on a search of Google. Their study found 70% of these firms were deficient
in protecting privacy or offering secure transactions. Most of the sites that met their
criteria for good privacy protection in their posted policies were online extensions of
existing licensed pharmacies. The study found a wide variety in privacy policies and
terms offered to consumers. However, their study was based on limited research
questions and methods when collecting information and analyzing the results. Three
relevant categories of privacy features were reviewed when compiling their results: (a)
company address and phone number provided, (b) promises of privacy of
personal/medical information, and (c) financial information sent online is secure
(PharmacyChecker.com, 2003c). Because of the limited information collected and the
lack of reliable research instrument modeling, that study was limited in its scope and
findings.
Dixon (2003) completed a study of 53 job search sites to review how each site
operates relative to consumer privacy information. She conducted a more comprehensive
review of privacy policy issues than the limited PharmacyChecker study, although this
study was limited to the online employment search industry. While her study
concentrated on privacy issues with online job search sites, some of her analysis can be
applied to studies of online Canadian pharmacies. For example, online firms of any
industry, not just the online employment arena, can use cookies, opt-in, opt-out, trust and
seal programs, and security of customer information and transactions.
6The study is also relevant because the number of online pharmaceutical firms and
customers using these sites is increasing every year. Online consumers are becoming
more sophisticated in Internet ordering, and have an increased awareness of online
privacy issues. They want the option of using sites that have acknowledged and easily
understood privacy policies. However, although they may desire high levels of privacy,
other factors, such as low-cost pharmaceutical products may override privacy concerns.
Significance
This dissertation will advance the area of privacy analysis of this industry by
providing a research methodology for analyzing privacy policies. This study is geared
towards a review of these issues among Canadian online pharmacies, but the methods
could be expanded to encompass an analysis of other online industries. It introduces
survey techniques and questions to aid researchers in effectively appraising consumers’
views on using these sites.
Barriers and Issues
To date, the goal of this study had not been met for a number of reasons. First,
although Canadian law may specify that sites must adhere to privacy regulations, the
rapid increase in the number of Web sites in this industry results in some sites not
understanding or adhering to all legal requirements. Large firms with budgets and time to
keep current with policies may have them posted on their Web site. Smaller firms may
either not be aware of guidelines or do not have the budget to adhere to them. In addition,
unethical firms likely have no desire to implement policies. Leizerov (2001) also states
that the rapid technological development of the Internet has presented an impediment to
7creating a framework for coherent rules, which could make it difficult for firms to stay
abreast of legislation or industry guidelines and best practices.
Although U.S. consumers enjoy considerable savings by using Canadian online
pharmacies, the practice of purchasing drugs from Canada and importing them to the U.S.
is illegal under U.S. law. Thus, consumers may not wish to complain if they encounter
problems with these firms. In addition, this industry has attracted many new firms over
the past several years, and not all these pharmacies are licensed in Canada. It should be
noted that some of these Web sites may promote themselves as “online pharmacies,” but
may merely be administrative or marketing corporations affiliated with either licensed or
unlicensed Canadian pharmacies. PharmacyChecker.com (2003b) has studied Canadian
online pharmacies and estimated that 50% do not hold valid Canadian pharmacy licenses.
This could lead to problems with wrong medication, fake drugs, or poor service. These
concerns, combined with lack of effective privacy policies, could heighten trepidations
consumers have with these organizations.
Another barrier to the study was the rapid proliferation of online pharmacies in
order to meet the rising demands of consumers looking for affordable medication. Jupiter
Research indicates that Canadian online pharmaceutical sales doubled to $584 million
from 2002 to 2004 (IMS Health Canada, 2005). As the number of online pharmacies and
sales increases, it becomes difficult to monitor the growing number of firms and their
privacy policies.
8Approach
The research was accomplished through the analysis of 25 online Canadian
pharmacy sites to determine what privacy policies they were following. First, best-
practice privacy policies and legal requirements were gathered to determine what specific
guidelines online sites should follow. Next, a data gathering review determined what
specific guidelines were used at each site, as well as those that were not included on the
policy page. Then, a questionnaire was compiled for users who frequented online medical
sites to assess their experiences and feelings of Canadian online sites.
The completed study included the following:
1. List of major general and industry-specific privacy policies that can be
included on Canadian pharmacy Web sites. The literature review aided in
the development of the research questions to compile in the site surveys. A
number of general privacy policy provisions that should be contained on
any Web site were included, as well as specific policies for the online
pharmacy industry. Some of these factors included: (a) privacy seal usage,
(b) demographic and personal information, (c) medical data, (d) use of
cookies, (e) profiling information, (f) opt-in and opt-out abilities, (g)
ability for users to update personal information, (h) disclosure of
information to third-party firms, (i) security protection, (j) collection of
data from children under 13 years of age in compliance with the
Children’s Online Privacy Protection Act (COPPA) law, (k) posting
changes to privacy policies on the site, (l) email or phone contact on the
9privacy page, and (m) pharmacy licensing and prescription requirements
on the site.
2. Compilation and analysis of Canadian (federal and provincial) and
American (federal and state) privacy laws. Legal considerations were
important in analyzing which sites follow regulations and to what degree
these laws are being adhered.
3. Selection of 25 online Canadian pharmacy sites chosen from two listings
to analyze their privacy policies. Half of the pharmacy list was compiled
randomly from the Canadian Online Pharmacy Directory (2004), an online
Web site service that aides U.S. citizens in locating Canadian online
pharmacies. The other portion of the list was gathered from a search of
Google.com. From these two sources, a final list of 25 Canadian
pharmacies was used for research on specific privacy policy issues. These
sites are included in Appendix A.
4. Analysis of each of the 25 sites to determine if they meet privacy policies
in relation to legal and best-practice requirements, as well as to identify
potential gaps. This was accomplished by examining the privacy policy
page for each site. A manual inspection of each page determined if
specific privacy factors were listed on the site, or whether the site included
those features.
5. Administration of a survey questionnaire for Internet users to determine
their views on Canadian online pharmacies. This survey consisted of a
series of questions and was hosted on an online site through
10
www.hostedsurvey.com. Some questions consisted of demographics, site
usage, and perception queries. Age and gender demographic inquiries
determined the type of users who normally utilize these sites. Other
questions established which factors were important to consumers when
they choose which sites to use. This information will be beneficial to
online Canadian pharmacies to determine how important privacy issues
are to the consumers versus other factors, such as cost or convenience.
6. Selection of online medical information sites that were used to create links
to the survey. In order to find a significant statistical survey of respondents
who utilize Canadian online pharmacies, it was imperative to select one or
more general medical information sites where the readers would be
inclined to need prescriptions, and thus use pharmacies to fill their
pharmaceutical needs. Of the respondents to the survey, it was anticipated
that some of them would have used Canadian sites. For those who did not
use online pharmacies, the survey questions queried why they did not,
such as concerns with privacy policies or legal issues.
7. Query of online users and analyzed the results. Statistical techniques were
defined to analyze the raw data. This included both an initial testing group
of 10 students and a final group of 147 consumers.
Resources
Accomplishing the objectives for this study required analyzing 25 online
Canadian pharmacies that cater to U.S. consumers. The researcher reviewed both licensed
as well as unlicensed firms. Many of the so-called “Canadian pharmacy” Web sites are
11
not truly licensed pharmacies, and merely function as facilitators between online
customers and traditional pharmacies. However, many operate under the guise of
legitimate pharmacies, and are often financially successful. Therefore, it was imperative
to study both legitimate, licensed firms as well as unlicensed sites.
A Web-based survey allowed for analysis of perceptions about Canadian
pharmacies. The audience consisted of U.S. consumers who utilized medical information
sites and were willing to take an online survey. The study analyzed both users and non-
users of online Canadian pharmacy sites to determine which factors (privacy policies,
cost, quality, etc.) consumers found the most influential in their choice of sites.
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Chapter 2
Literature Review
Introduction
The growth of Canadian online pharmacies is a phenomenon resulting from the
price differential between American and Canadian prices for medication. Lack of
insurance and high prices for pharmaceuticals have resulted in many American
consumers bypassing U.S. pharmacies for the lower-priced Canadian market.
PharmacyChecker.com, an independent research firm, collects and analyzes online
pharmacy data. They indicate that because of Canadian price controls on drugs,
pharmaceuticals sold in Canada are, on average, 50% lower in cost than the same drug in
the U.S. (PharmacyChecker.com, 2003e). The savings have attracted U.S. consumers to
these sites, but the migration has not come without controversy, such as lack of consistent
and comprehensive privacy policies.
According to data from IMS Health, a company that studies the pharmaceutical
market, Americans fill over three billion prescriptions annually, generating over $200
billion in revenues (Fox, 2004a). She indicates chain stores account for the largest
segment of pharmacy sales (36.2%), followed by independent drug stores (14.4%), and
mail order services (13.8%). Currently, only 4% of all U.S. pharmacy consumers have
purchased prescription drugs online. Concern about disclosing personal information
online is a concern for consumers across retail sectors (Resnick & Montania, 2003).
Privacy concerns make online disclosure of medical information an especially sensitive
13
issue to online consumers (Choy, Hudson, Pritts, & Goldman, 2001). In addition,
consumers express apprehension about the quality of prescription drugs purchased online,
particularly if the pharmacies are not licensed in the United States and thus not subject to
U.S. safety and quality standards (Fox, 2004a).
With poor online privacy practices, many companies will experience negative
effects not only on their online sales, but also in a shift of customers to more privacy-
sensitive competitors (Dienekis Information Systems, 2004). It would follow that online
service firms might alleviate customers’ concerns by developing and posting a
comprehensive privacy policy on their Web sites.
Political Issues with Online Pharmacies
Pharmaceutical prices in the U.S. far exceed those of most other Western nations,
and U.S. consumers find that they are often unable or unwilling to pay the established
prices (Cohen, 2004). Additionally, in 2004, 15.7 percent of the American population
lacked insurance to cover prescription drug costs (U.S. Census Bureau, 2005) and the
option of purchasing lower-cost drugs from foreign firms becomes attractive. Unlike the
U.S., some foreign countries set maximum prices for pharmaceuticals in order to make
them affordable for their citizens. For example, Canada has a federal board that sets price
ceilings on drugs (Krauss, 2004; Parloff, 2004). The purchase of drugs from Canadian
pharmacies over the Internet has become a topic of heated debate that extends to the U.S.
Congress and state legislatures. The governors of Illinois, Minnesota, New Hampshire,
and Wisconsin have established online directories of recommended Canadian pharmacies
(Fox, 2004a). The governors of Iowa, Maine, Michigan, Ohio, Vermont, and West
Virginia have expressed similar interest in providing their residents with online access to
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Canadian pharmacies (Korcok, 2004). Michael Albano, mayor of Springfield,
Massachusetts took the initiative in arranging for Springfield’s 9,000 municipal
employees to purchase drugs from a designated Canadian pharmacy at an estimated cost
savings of $4 million to $9 million annually (Korcok, 2004). As of December 2003,
about 3,300 employees had used the program, saving the city roughly $1 million (Parloff,
2004). The average savings to U.S. consumers is substantial. The U.S. Senate
Subcommittee on Consumer Affairs, Foreign Commerce, and Tourism reviewed a study
by the United Health Alliance, a nonprofit physicians’ health group. A study of 145 U.S.
senior citizens showed that U.S. citizens paid $81,000 for their prescriptions in the U.S.
and only $22,000 for the same prescriptions in Canada (U.S. Congress, Senate, 2001).
Both the pharmaceutical industry and the U.S. Food and Drug Administration
(FDA) have expressed powerful opposition to U.S. citizens purchasing Canadian
pharmaceuticals because they cannot guarantee the safety of drugs imported from outside
the U.S. (Hubbard, 2003; Meadows, 2002). Advocates counter that their motives are
based on economic factors and profits rather than on safety concerns (Cohen, 2004).
Alternately, opponents of Canadian drug importation have accused some Canadian
Internet pharmacies of the same profit motive (Whitbaum, 2003).
The “political gridlock” over extending prescription drug benefits to Medicare
beneficiaries generated “anger and despair” among older adults and many have
difficulties paying for needed drugs (Korcok, 2002, p. 1). In 2002, Congress failed to
pass a proposed measure that would ease access to the re-importation of cheaper
prescription drugs from Canada. Noting that the government covers 75% of prescription
drug costs for congressional members, Senator Edward Kennedy (D-MA) spoke out,
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“How many of us are willing to face our constituents… knowing that we have secure
coverage…but we reject proposals that do even less for our fellow citizens?” (Korcok,
2002, p. 1). Parloff (2004) stressed that support for legalizing access to Canadian
pharmacies is not a partisan issue.
Consumer Economic Issues
The dispute over purchasing drugs from online Canadian pharmacies may be
rooted in a variety of issues related to e-commerce practices and how the online
pharmacy industry operates in the context of the global online economy, especially the
legal and moral aspects related to privacy. There are differences and similarities in both
the privacy policies and pharmacy regulations of the U.S. and Canada. To many people,
cyberspace is a vast entity that allows them anonymous exploration with an assumption
their surfing habits and information is protected. However, the existence of cookies and
Web bugs (clear gifs) belies any assumption that online browsing is really anonymous
(Olsen, 2000). On the contrary
Every time an individual interacts with the Web, she or he leaves behind a trail of
extraordinary detailed information about their identity, preferences, hobbies,
buying habits, financial status, and even medical records. This private information
of customers can be—and actually is—used and abused (Reisch, 2003, p. 103)
Regarding the issue of consumers providing their personal information to online
health sites, Choy et al. (2001) stated, “The potential for abuse is enormous” (p. 25).
Consumers engage in a cost-benefit analysis when they decide to purchase online. On one
side are their concerns with privacy and security; on the other side are factors such as
convenience, cost, and 24-hour access. Adults who have used the Internet for finding
16
health information or buying health-related products (including prescription drugs)
acknowledge the legitimacy of arguments on both sides (Fox & Rainie, 2000). The
decision that the benefits outweigh the potential costs of making a purchase online is
typically based on consumers’ perceptions that the vendor will treat them fairly
(Pennington, Wilcox, & Grover, 2003). Visible signs such as privacy seals, guarantees,
and customer ratings enhance consumer’s perceptions of trust of Internet sites
(Pennington et al., 2003).
Reisch (2003) outlined the potential benefits and pitfalls of online commerce for
consumers. The benefits of online shopping include:
• Lower transaction costs with respect to time, money, and access to product-
related information and services.
• Lower costs of consumer organization, including the potential for networking,
strategic alliances, virtual consumer organizations, information access and
transparency, power shopping, comparison shopping, price agents, and
consumer platforms.
• Entertainment and stimulation due to the interactive nature of the medium.
• Individualization in the form of customized information and advertisements.
Reisch (2003) notes that, “While these promises are intriguing, there is a dark side
to Internet technology usage” (p. 99). Two of the “dark” factors she mentions are relevant
to this study privacy and security. She states
The privacy of consumer information that is collected for commercial purposes is
seen as a distinct consumer right from both legal and ethical perspectives, and the
17
secure storage and transmission of consumer information is regarded as an
integral step in maintaining that privacy. (Reisch, 2003, p. 99)
However, the vast amount of information stored in business databases, combined
with lack of national privacy legislation, inconsistent self-regulation of online firms, and
consumers’ lack of understanding about protection of their private information contribute
to the risk of breaches of consumer privacy. Reisch (2003) states, “it is not usually the
disclosure of data that is problematic, so long as it is provided voluntarily and as long as
users are made fully aware of how this information is going to be used” (p. 100). The
disclosure of information is often mandatory if customers want to use online sites and
complete electronic transactions. However, serious privacy problems can arise when the
information is shared with business affiliates outside the control of the host Internet site.
Howard Beales (2002) states that the focus of consumer privacy protection should
be on “misuse of information” (p. 1). Whereas data collection had been the previous
focus of the FTC’s Bureau of Consumer Protection, the current focus is on preventing the
abuse and misuse of information that has been voluntarily disclosed.
Beales (2002) describes the FTC’s 2002 privacy agenda involving pharmaceutical
manufacturer Eli Lilly and Company. The complaint presented to the FTC alleged that
Lilly did not take appropriate actions to protect the security and confidentiality of
information provided to Lilly.com and Prozac.com. The result was that Lilly
inadvertently disclosed the e-mail addresses of 669 visitors to those sites. Underscoring
the privacy concerns of consumers who use the Web for health information and drug
purchases, Beales noted, “This was very sensitive information, where release could have
serious adverse consequences for the consumer involved” (p. 2).
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Another issue related to privacy abuse, can occur when companies violate their
own privacy policies. McCullagh (2004) iterates that although consumers may research a
site’s policies, this action becomes questionable if the online firm does not adhere to the
stated policies. Not only does this problem occur with private industry, but it also has
occurred with U.S. government entities. In January 2004, the U.S. Department of the
Treasury planned to publish nearly 10,000 e-mail addresses on the Web, violating its
privacy promise to consumers who used e-mail to comment on a government proceeding
(McCullagh, 2004).
Purchasing prescription drugs from Canadian pharmacies online provides unique
benefits to U.S. consumers who often shoulder a high cost burden. However, the legal
and ethical issues of purchasing from the online market challenges what has historically
occurred in the past with legislation and regulation. The following sections will address
the issues of privacy and trust from its broader perspectives to the specific application of
purchasing pharmaceuticals online from Canadian pharmacies.
Privacy Policies, Practices, and Preferences
Privacilla.org is a coalition of businesses and individuals encouraging a pro-
technology and free-market economic view and endorses strong privacy rights on the
Web (Privacilla.org, 2002). Privacilla.org (2003, p. 3), formulated a definition of privacy
designed to “solidly capture the concept of privacy.” The organization claims that failure
to define the term within the context of the cause in which it is being used has resulted in
failed policy initiatives. For the purpose of preventing the abuse and misuse of
information provided by Internet consumers
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Privacy is a state of affairs individuals experience having to do with the amount of
information about them that is known to others and on what terms. Specifically,
privacy is the subjective condition that people experience when they have power
to control information about themselves and when they have exercised that power
consistent with their interests and values. (Privacilla.org, 2003, p. 30)
Privacilla.org’s definition of privacy is intended to protect the privacy of
consumers without restricting information sharing by marketers. Privacilla.org (2003)
contends that the legal regulation of information sharing among corporate affiliates
(which has been promulgated in California) has more negative than positive potential
effects and does not correspond with the desires of most consumers. According to
Privacilla.org (2003), “Perhaps the most important, but elusive, part of privacy protection
is consumers’ exercise of power over information about themselves consistent with their
interests and values” (p. 4). In fact, California regulations are more consistent with the
European Union’s more stringent regulations on gathering, aggregating, and buying or
selling consumer data (Reisch, 2003). California’s Online Privacy Protect Act of 2003
became effective on July 1, 2004. It requires operators of commercial Web sites who
collect information about California residents to post their privacy policy conspicuously
on their Web site (“California Online,” 2003). Cadogan (2002) predicts that the global
nature of e-commerce will generate a trend in that direction.
Volokh (2000, p. 88) acknowledges that U.S. law currently places few restrictions
on the communication of information by private parties. However, contract law can be
used to enforce protection. He states, “If a business promises to keep information private,
consumers can hold it to that promise.” They can also threaten not to deal with businesses
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that refuse to uphold privacy obligations--“a powerful threat in today’s competitive
marketplace” (p. 88). Arrison (2002) agrees that the primary control for Internet privacy
lies in contracts, not regulators. Arrison argues that it is in the best interests of online
businesses to respect the privacy concerns of consumers since they can simply switch to
another retailer. She also contends that consumers are best served if they provide
information that enables them to receive customized information and perks. Thus,
Internet businesses have the obligation to respect consumers’ privacy, thus leading to
making consumers more comfortable in disclosing personal information to the mutual
benefit of both parties. Essentially, legal regulations, self-regulation, and consumer
preferences interact to maintain ethical privacy practices.
The research reviewed for this project supports the assertion of Privacilla.org
(2003) that consumers’ privacy preferences vary considerably. However, concerns with
privacy are ubiquitous in the literature and are especially prominent when the topic is
related to disclosing consumers’ medical information.
Privacy and Trust
Culnan and Bies (2003) define information privacy as “the ability of individuals
to control the terms under which their personal information is acquired and used” (p.
326). The authors maintained that consumers’ perceptions of fairness play a key role in
their willingness to disclose personal information. Alternatively, individuals are willing
to disclose personal information for some social or economic benefit, as long as
disclosing the information will not cause them harm. While there is a large body of
research supporting this premise in the context of interpersonal relationships, Culnan and
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Bies stress that it applies to consumer relationships, and can thus be applied to a variety
of online and physical marketplaces.
Culnan and Bies (2003) note that the U.S. government currently takes a reactive
mode with regard to consumer privacy issues. Congress typically takes action only after a
specific problem has been identified and then reactively attempts to correct the issue only
after each specific issue is identified. This is why there are separate laws and regulations
governing medical records, financial records, credit reporting, information collected from
children, and other similarly focused legislation. In most cases, legislation is enacted
when businesses and consumers demand the government to act.
Culnan and Bies (2003) suggest that this conventional approach is inadequate in
the face of consumer concerns over disclosing information online. They predict that
persistent consumer concerns about privacy may ultimately lead the U.S. federal
government to pass online privacy legislation for a number of reasons. First, consumers’
apprehension about privacy threatens to hamper full utilization of online commerce.
Second, alternatives to government legislation, such as self-regulation and technology,
have not proven sufficiently effective. Government regulation is not the most cost-
efficient solution, since it could raise the cost of doing business online. At the same time,
“consumers incur significant costs in the absence of adequate privacy protection” (p.
333). To protect consumers, Culnan and Bies advise that, “To forestall government
intervention, corporations need to regulate themselves in an enlightened manner” (p.
333). Ultimately, they predict that a synthesis of “self-regulation, technological solutions,
legal solutions, and a vigilant media will be required over time to successfully protect
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consumer privacy and address the range of preferences of American and global solutions”
(p. 337) so consumers will see more benefit than cost in disclosing information online.
Consumer concerns about online privacy impede the full potential of the Internet
and electronic business. The tremendous growth in e-commerce is illustrated by online
retail sales in the U.S. soaring to $114 billion in 2003 (National Research Federation,
2004). Despite this growth, the figure falls short of the $380 billion projected by Forrester
Research for 2003. Internet sales began to slow even before the 2001 economic
stagnation and the dot-com bust; in fact, the slower than projected growth is often
attributed to issues of consumer trust in online vendors. According to surveys of Internet
users, two prominent concerns are perceptions that Internet businesses have poor, slow,
or negligible customer service and customer apprehensions about disclosing personal
information online. Resnick and Montania (2003) classify both these issues under the
heading of “trust.”
Consumer trust has been a focus of research across a wide variety of disciplines,
and authors from a variety of areas have studied how human interactions affect trust.
Hosmer (1995) states that trust involves an element of vulnerability. The person who
places trust in another is vulnerable due to the lack of control over the actions of the other
party. Based on published literature, Hosmer arrived at a definition of trust that is simple
and applicable to a variety of economic exchanges, and advocates ethics. From this
perspective
Trust is the reliance by one person, group, or firm upon a voluntarily accepted
duty on the part of the other person, group, or firm to recognize and protect the
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rights and interest of all others engaged in a joint endeavor or economic exchange.
(Hosmer, 1995, p. 393)
Culnan and Bies (2003) emphasized that it is unrealistic to ensure trust as a
complete reliance “upon a voluntarily accepted duty.” However, evidence indicates that
consumer trust is an important condition of both online and physical business commerce
(Resnick & Montania, 2003). Consumers’ perceptions of trust influence their desire to do
business with a seller, and mutual trust between the two parties enhances the quality of
economic interactions and results in more satisfaction between each party (Pennington et
al., 2003). Trust has long been recognized as a key factor in customer loyalty, and
perceived lack of trust (such as lacking a comprehensive stated privacy policy) can have
negative repercussions on a firm.
Other definitions of trust indicate both its moral and ethical dimensions (Hosmer,
1995). Rose (2000) used the term “moral hazard” to describe the conditions under which
Internet commerce takes place.
Moral hazard means one party’s actions are not observable by the other so the one
in the dark must bear all the costs of protecting themselves but in doing so they
will only receive some of the potential benefits of the transactions. (p. 23)
Consumers can protect themselves to some extent, but they have no control over the sale
of their data to others. In addition, if they withhold information from Web sites, they lose
the benefits of customization and various perquisites offered by different sites, and may
not even be able to engage in online sales. However, consumers find ways to bypass
marketers’ required information by not giving accurate data. Forty percent of online
consumers report sometimes providing fictitious data, so the marketer can find they have
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inaccurate data. Culnan and Bies (2003) emphasize that optimal business relationships
are characterized by trust on both sides.
Online commerce involves new technologies that enable storage and sharing of
unprecedented amounts of information. Reisch (2003) states that making e-commerce
safer and more secure involves a combination of legal, economic, and educational
solutions in which all stakeholders must play an active part. The strategies Reisch
recommends include government enforcement of new laws and regulations; consumer
education; industry self-regulation and voluntary guidelines; third party verification
systems, guarantees, and seals of approval; and the support of technological platforms.
Electronic Commerce and Trust
Pennington et al. (2003) proposes using system trust to define how consumers
place their trust in online vendors. The authors define system trust as “a belief that the
proper impersonal structures have been put into place enabling one party to anticipate
successful transactions with another party” (p. 201). Pennington et al. (2003) views
system trust from two perspectives. The first involves structural assurances or
safeguards, such as regulations, laws, guarantees, and contracts that decrease consumers’
perceived vulnerability and increase their trust in online firms. The second involves
situational normality, “which makes the situation appear normal and reduces uncertainty
in the transaction” (p. 201).
According to Resnick and Montania (2003), “Whereas trust develops over time,
communicating trustworthiness must occur as soon as interaction with a site begins” (p.
212). Consumer research on face-to-face interactions, such as in traditional, non-
electronic commerce, has found that competence, dependability, and likeability are key
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factors in customers’ trust (Pennington et al., 2003). In Internet transactions, the user
interface and design of a Web page plays a role in defining the degree of consumer trust.
According to Fogg et al. (2002), a Consumer WebWatch research report of 2,684 people
evaluated the credibility of two Web sites to review 18 areas that people use when
evaluating Web site credibility, and was one of the largest studies assessing how
consumers evaluate Web sites. The study found that consumers often base their
credibility decisions on the visual appeal of the Web sites as opposed to conducting
unbiased evaluation strategies when assessing sites.
Online firms can use several methods to enhance trustworthiness of their sites.
One method that increases consumers’ level of trust is the use of privacy seals. Seals
guaranteeing privacy and security may be supplemented by a rating system or “star”
system denoting how well the site performs according to a set of criteria that offers
evidence of vendor performance as perceived by users. Another way is the presence of a
vendor statement that includes information about privacy and security as well as specific
information for the type of transactions being conducted. However, Pennington et al.
(2003) note that these statements do not necessarily include verification by third parties.
Pennington et al. (2003) explored consumer perceptions of trust in an
experimental survey of 266 Internet users (170 women and 92 men with an average age
of 42 years). Most reported going online daily, making purchases online, and frequently
surfing the Web to find product information. The participants were told to browse a
specially designed Web site as an online shopper in search of a DVD. They were
instructed to click on any symbols offering additional information about the site. Upon
completing the task, the participants were asked to fill out a questionnaire about their
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experience with the site and submit it in order to be eligible to win a prize. They were
also requested to fill out a page of personal information that would allow them to be
contacted if they won (personal information was carefully separated from subject
responses to maintain research anonymity).
Based on their results, Pennington et al. (2003) concluded that system trust is “a
‘controllable’ construct that can be used to directly influence perceived trust” (p. 213).
Sites can use a variety of measures designed to promote trust and to influence consumers’
positive perceptions of the Web site. Pennington et al. (2003) found that the site’s
reputation, often based on the firm’s past performance, was found to be an important
predictor of trust. The use of self-reported guarantees, such as money-back guarantees
and assurances of security or privacy positively influenced consumers’ trust and created a
positive image regarding the site. Interestingly, vendor guarantees, which have no third
party verification, proved more predictive of system trust than third party seals (pp. 213-
214). Pennington et al. (2003) proposed that third party seals are probably more closely
linked to issues related to actual purchases, which were not part of the study. The study
offered a valuable framework for exploring trust in the area of online business and
commerce (pp. 213-214).
Resnick and Montania (2003) explored using online trust with semiotics, “the
study of signs and symbols that convey semantic and syntactic content and their use as a
communicative tool” (p. 212). In the retail environment, “trust is the belief or expectation
that the word or promise by the merchant can be relied on and the seller will not take
advantage of the customer’s vulnerability” (p. 213). In the arena of online commerce,
trust is vital for the success of a firm
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A customer at an online commerce site lacks concrete cues to comfortably assess
the trustworthiness of the site and therefore must rely on new kinds of cues. The
interpretation of these cues drives the development of customer expectations of
the trustworthiness of the vendor. (Resnick & Montania, 2003, p. 213)
Resnick and Montania (2003) maintain that the impact of Web site design rests on
consumers’ perceptions of three factors that influence decisions to purchase: customer
service, reputation management, and privacy. The researchers created Web pages for
fictitious Internet retailers selling flowers and related gifts. They varied the sites
superficially to ensure they appeared as four distinct retailers while keeping basic
information, such as prices, the same. Three important areas distinguished one firm from
another: the presence and prominence of customer service links, customer ratings, and a
privacy policy. After a pilot test, Resnick and Montania conducted their study on a
sample of 64 adults ranging in age from 18 to 53 years. Most were frequent Internet users
(83%) and 78% had purchased items online. The participants were told they were testing
the usability of new Web sites.
Resnick and Montania (2003) found that each of the three “trust-focused” design
elements had a significant impact on the participants’ preferences for the Web sites and
on their expectations of customer service, privacy protection, and merchandise quality.
The authors state, “The presence or prominence of all three design parameters were
positively associated with users’ perceptions of each site and from this site they chose to
make their purchase” (p. 230). They found neither the customer service links nor the
privacy policy links offered explicit information on how much customer service would be
provided or how the Web site protected consumers’ privacy and personal data. However,
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these links did enhance consumer perceptions that the sites did a good job with privacy,
thus enhancing trust (p. 230). An interesting point was that a prominent display of
product ratings also increased the subjects’ perceptions of privacy protection. This result
was not what the researchers had anticipated. They hypothesized that, “This effect may
be due to a perception that other customers were happy with the company’s performance
in general and this generalized to include privacy protection perceptions” (pp. 230-231).
Pennington et al. (2003) and Resnick and Montania (2003) used concepts derived
from marketing research and applied them to online commerce. Mears, MacNeil, and
DeJarnette (2003) contend that the e-commerce explosion acts as a driving force in
“reshaping the very nature of trust” (p. 1). These “new business drivers” include:
• Blurred borders: as more companies diversify and expand, “the lines defining
where they begin and end become less apparent, legally, physically, and
culturally” (p. 1).
• Virtual marketplace: the environment where consumers and vendors interact
is created by a Web site’s ability to elicit and “intelligently” use consumers’
personal information.
• Data aggregation: as the tools for collecting, aggregating, and disseminating
data proliferate, both individuals and companies are concerned about privacy
risks.
The concepts of consumer privacy and trust originated long before the advent of
online commerce. However, the nature of electronic commerce requires new mechanisms
and legislation to protect the privacy of consumers’ personal information. For online
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commerce to reach its potential will require addressing consumer concerns and building
trust to a degree at least equal to that involved in face-to-face interactions.
Privacy Policies
The protection of privacy in the U.S is a mixture of laws, court decisions, and
self-regulation (Larson, Larson, & Greenlee, 2003, p. 50). Other sources point out that in
the U.S., “a consumer’s privacy is protected primarily by the goodwill of businesses” (p.
50). While this practice may have sufficed in the realm of traditional commerce, few
consumers are willing to disclose personal information online based on faith in the
vendor’s “goodwill.” American business sources tend to express a preference for
contracts over regulation as the major method for controlling information flow and
commercial interactions (Arrison, 2002). Different types of transactions fall under the
jurisdiction of different agencies. Online pharmaceutical companies generally fall under
the jurisdiction of the FDA, which controls the importation and safety of the drugs, and
the FTC, which enforces consumer protection laws (Sweet, 2001).
Rothstein (2001) found both differences and similarities between the privacy
protection provided by U.S. and Canadian legislation. The similarities outweigh the
differences since both countries have laws at both the federal and state or provincial
levels. However, the Canadian regulations are more comprehensive than U.S. laws,
which lack uniformity, and differ among the various states.
Kobsa (2002) specifies that, “Privacy laws protect the data of identified or
identifiable individuals” (pp. 65-66). Privacy laws have been enacted by more than 30
countries as well as by U.S. states and Canadian provinces. Kobsa contends that while
privacy laws have numerous superficial differences, they are generally founded on a
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small number of privacy principles. These principles are derived from recommended
privacy guidelines adopted by the Organization for Economic Cooperation and
Development (OECD) in 1980. The OECD privacy principles include: (a) Collection
Limitation Principle, (b) Data Quantity Principle, (c) Purpose Specification Principle, (d)
Use Limitation Principle, (e) Security Safeguards Principle, (f) Openness Principle, (g)
Individual Participation Principle, and (h) Accountability Principle.
Kobsa (2002) advocates the enactment of an international treaty on information
privacy. Whether that is feasible in the near future, the virtually universal concern for
online privacy will encourage businesses and government to coordinate self-regulation
and legislation to alleviate privacy concerns and conflicts.
Canadian and U.S. Health and Medical Information
The Health Insurance Portability and Accountability Act of 1996 (HIPAA) has
provisions called “administrative simplification,” designed to promote development of a
uniform, technology-based health information system (Choy et al., 2001). Part of HIPAA
regulations is the “Privacy Rule,” which became effective as of February 26, 2001. It is a
set of basic national privacy standards and fair information practices that protect
Americans' personally identifiable health information (Rothstein, 2001). With the
understanding that privacy is of utmost importance, Congress included a requirement that
if it did not enact health privacy legislation by legislative deadline, the Department of
Health and Human Services would be required to do so. However, the authority of the
Department only extended to three health care entities: health care providers, health
plans, and health care clearinghouses. This limitation excludes many health-related Web
sites. Thus, depending on the owner or operator of a given Web site, a site offering health
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or medical services, including prescription drug sales, may not be covered by HIPAA
rules. Choy et al. (2001) and Rothstein (2001) concur in stating that part of the HIPAA
regulations specifies which “covered entities” fall under these auspices, and these may
not include some types of Internet based pharmacies
Canadians are protected by two pieces of legislation: the Privacy Act and the
Personal Information Protection and Electronic Documents (PIPED) Act. The Privacy
Act (1983) protects Canadian citizens by placing controls on the collection and use of
private information. The PIPED Act (2001) regulates how private industry is able to
collect and use personal information about its customers (Canada Privacy Commissioner,
2002).
The Privacy Commissioner of Canada has stated that, “Personal health
information—information about the state of our bodies and minds—is arguably the most
private information of all. When that information is not treated with the utmost care and
confidentiality, the consequences can be disastrous” (Canada Privacy Commissioner,
2003a, p. 24). PIPEDA covers health information broadly, as it applies to all personal
data collected, used, or disclosed in the course of commercial transactions (McCutcheon,
2002). The basic principle of PIPEDA is that individuals have the right to consent to
having personal data collected, used, or distributed. Additionally, PIPEDA outlines 10
principles of fairness with which organizations are expected to comply. The expectations
for privacy, both explicit and implicit, in PIPEDA far surpass the perfunctory legal
efforts to guard information privacy in the U.S.
Beginning January 1, 2004, pharmacists in Canada were required to comply with
PIPEDA. Patients, including those utilizing online sites, must be informed of what
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information is being collected, how the information will be used, and with whom the
information will be shared (Canadian Pharmacists Association, 2004).
Rothstein (2001) used the term “patchwork” to describe the industry-specific U.S.
laws that operate within a system of self-regulation. This includes the recent enactment of
a “detailed medical privacy law” that “covers actions of both public and private actors”
(p. 345). Rothstein predicts that the growth of online pharmacies will lead to greater
consistencies in the regulation of health information between Canada and the U.S.
However, American businesses across sectors are reluctant to give up the self-regulation
that appears to have served the economy well for so long.
Rothstein (2001) divides online pharmacies into three categories: (a) pharmacies
that offer a limited number of select drugs, (b) pharmacies created from brick-and-mortar
pharmacies, and (c) “full service virtual pharmacies” such as drugstore.com (p. 53).
Many pharmaceutical firms also have online presences to provide consumer and
professional information. The Eli Lilly case illustrates how these sites can jeopardize
personal information as a consequence of lax privacy procedures (Beales, 2002).
In the Eli Lilly case, the breach of privacy was unintentional and due to failure to
adhere to privacy protection protocols (Beales, 2002). Surveys of health professionals
with access to sensitive medical information have reported that they recognize inherent
threats to consumer privacy and support measures designed to minimize them (Baumer,
Earp, & Payton, 2000). The recommendations of health professionals largely correspond
with administrative proposals.
Pharmacies based in the U.S. are subject to both federal and state regulations
(Rothstein, 2001, p. 358). Federal laws primarily cover the handling of personally
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identifiable health information by federal agencies and their private subcontractors. State
laws present the most powerful mechanism for controlling consumer health information
and records, although the laws vary considerably by state and address different concerns,
often related to the era in which they were enacted. However, Rothstein (2001)
emphasizes “providing health services over the Internet is a multi-jurisdictional activity
that could, in theory, implicate the law of all 50 states” (p. 358).
In addition to protection under PIPEDA, the Health Information Privacy Code
provides the Canadian health care industry with an industry-specific self-regulatory
mechanism for protecting the privacy of personal health data (Rothstein, 2001). PIPEDA
was enacted to address gaps in protection resulting from the government-sponsored
single-payer of health care. Under these laws, Canadians are better protected from the
misuse of health and medical information than their American counterparts. In January
2004, the Canadian Pharmacists Association issued a statement detailing the privacy laws
under PIPEDA and the Health Information Privacy Code, as well as addressing the
provincial legislation governing privacy protection (Canadian Pharmacists Association,
2004).
Pharmacy regulation
The difference in privacy laws between the U.S. and Canada can raise a significant
issue among the posted policies for Canadian online pharmacies. Although these sites
originate in Canada and are bound by Canadian laws, they affect American consumers.
Canada has more stringent legal protection for its businesses than those that operate in the
U.S. and are covered by a myriad of provincial and federal regulations.
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American privacy and online pharmacy Internet protection falls under a multitude
of agencies and regulations. According to Sweet (2001), online pharmaceutical firms are
under the primary jurisdiction of two agencies, the FDA and the FTC. The FDA controls
the importation and safety of the drugs. The FTC enforces consumer protection laws,
such as privacy policy postings on Internet sites. According to Rothstein (2001), U.S.
privacy protection dealing with medical records contained on American Internet sites
could fall under HIPAA legislation. One portion of HIPAA regulations is the “Privacy
Rule,” which became effective February 26, 2001. This rule outlines privacy standards
and fair information practices that protect Americans' personally identifiable health
information.
Another legal issue that affects the online pharmacy arena is the 1994 North
American Free Trade Agreement (NAFTA). This Agreement eases border restrictions
between the U.S., Mexico, and Canada. However, Graham (2003) states that the cross-
border pharmaceutical trade violates the principles of free trade and possibly NAFTA. He
indicates that due to the cross-border trade in pharmaceuticals, the Canadian government
is not giving foreign-owned manufacturers “fair and equitable treatment and full
protection and security,” (p. 17) one of the articles of NAFTA.
Both Canadian and U.S. pharmacies are regulated at both the federal and state or
provincial levels (Rothstein, 2001). In addition, pharmacies in both countries must obtain
licensure in the state or province where they are based. In 40 states, legislation requires
that out-of-state pharmacies or non-resident pharmacies selling prescription drugs comply
with a specified set of regulations that range from providing evidence of licensure to
maintaining a toll-free telephone line (displayed on each prescription drug label) that
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enables customers in the state to communicate with the pharmacy (U.S. General
Accounting Office, 2000). Since 1998, several states have enacted legislation to regulate
Internet pharmacies: Indiana, New York, Illinois, California, New Hampshire, Arkansas,
Nevada, and Texas (Gordon, 2004). The states vary in their specific laws but, in general,
all require that online pharmacies comply with state regulations and licensing laws and
maintain a specifically designated governing body.
State and federal legislatures may propose laws to protect consumers who utilize
online pharmacies, but not all proposals are enacted. For example, one of the initiatives
proposed by the Clinton Administration in 1999 was to protect consumers from the
illegal sale of prescription drugs via online Internet sites. Part of the proposal was a new
Federal requirement to enable consumers to identify legitimate Internet pharmacy sites,
as well as strengthening FDA authority to investigate the sites (U.S. White House, 1999).
The U.S. General Accounting Office (2000) and FDA official Hubbard (2003)
emphasize that they recognize the potential benefits of online prescription drug
purchasing for American consumers. Hubbard cites several factors that consumers find
positive, especially those individual who are disabled or ill. These benefits include ease
of use, convenience, privacy for consumers who have problems they do not wish to
discuss in person, and vastly expanded information access. He also proposed that
technology could reduce medication errors, thereby making prescription drug purchases
safer. The FDA’s main concern is the safety of prescription drug sales by pharmacies
outside U.S. jurisdiction.
The FDA has traditionally exempted the importation of drugs from Canada from
federal restrictions under the “personal use” guideline. This action makes it legal for
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Americans to bring in small quantities of prescription drugs (no more than a three-month
supply) for personal consumption (Parloff, 2004). Recognition of this guideline inspired
enterprising pharmacists in Manitoba and Winnipeg to establish the first online
pharmacies targeting U.S. consumers, RxNorth.com and CanadaMeds.com, respectively.
Within a short time, the pharmacy sites were thriving businesses that generated a
proliferation of online pharmacies and a tremendous amount of publicity, both good and
bad.
The dominant reason for American consumers’ interest in Canadian pharmacies is
the cost of prescription drugs in the U.S. compared to the relatively lower prices in
Canada. There are several reasons for the higher prices in the U.S. One is the overall
expense of health care in the U.S. compared to other countries, and the second is the
amount of money U.S. pharmaceutical firms invest in research and development (R&D)
(Cohen, 2004; Graham, 2003). The paradoxical effect of the investment in R&D is that
prescription drugs imported from Canada are frequently re-imported. That is, despite
alleged concern over the manufacture of drugs outside the U.S., many were manufactured
in the U.S. Because of the high cost of R&D, pharmaceutical firms pass the costs on to
consumers.
There is a third reason, however, for the large difference in cost between the two
countries, pharmaceutical price controls imposed by the Canadian government.
Statements by U.S. officials indicate that these controls present problems for U.S.
consumers. In November 2004, FDA Chairman Mark McClellan attacked Canada’s price
controls and stated they encourage illegal activity, contribute to unsafe cross-border
safety risks for unapproved drugs, and reduce funding for drug research (Webster, 2003).
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However, a Canadian health analyst suggested that the attack was a “smoke and mirrors
game” and suggested that the FDA’s remarks were inappropriate (Webster, 2003). The
FDA has strengthened its opposition to the businesses engaged in this online commerce.
Thompson (2004) stated that in November 2003, the FDA took legal action against a
U.S.-based online pharmacy, Rx Depot, and a federal judge sided with the courts to shut
down the firm. Thompson further explained that since the FDA faced significant legal
challenges in bringing charges against Canadian-based pharmacies, the FDA may take
legal action against states and cities that are encouraging this practice. In addition, in
2000, the FTC settled charges with a group of online pharmacies that indicated they
operated medical and pharmaceutical facilities they did not have or did not adhere to their
stated privacy policies (U.S. Federal Trade Commission, 2000b).
Although the FDA has taken action against online business, they have been less
likely to act against individuals. Whitwham (2003a, p. 759) references Jeff Poston,
executive director of the Canadian Pharmacist Association, saying that the FDA does not
interfere with consumers engaged in cross-border commerce because many of them are
senior citizens without insurance. He claims that if the FDA proceeded to prosecute these
seniors, they would have a difficult moral position to defend. The FDA would also face
the political wrath of seniors and other consumers who purchase Canadian drugs.
U.S. consumers’ increased use of Canadian mail-order pharmacies has led to
repercussions for Canadian consumers and pharmacists. The pharmaceutical companies
have considerable influence and have used this power in an effort to limit the growth of
the online Canadian pharmacy industry. Since January 2003, several major international
pharmaceutical firms, including GlaxoSmithKline, Pfizer, AstraZenica, and Wyeth have
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made individual efforts to halt the importation of drugs from Canada into the U.S.
(Cohen, 2004; Korcok, 2004; Parloff, 2004). In January 2003, GlaxoSmithKline, the
world’s second largest pharmaceutical manufacturer, sent letters to Canadian Internet
pharmacies announcing they would stop supplying products to pharmacies that sold drugs
to U.S. consumers (Gregoire, 2003). Those pharmacies that also sold products to
Canadian as well as U.S. consumers could find they can no longer service either group,
thus leaving Canadian citizens with fewer pharmacy choices. Vivian (2003) states that in
early 2003, the U.S. FDA issued a policy letter against businesses that re-import
prescription drugs from Canada. The FDA also warned Congress that mail-order
pharmacies are breaking current U.S. law could face stiff criminal penalties, and warned
that re-importation could result in counterfeit drugs reaching U.S. patients.
Canadian officials in business and government have expressed concerns that the
flow of drugs into the much larger American consumer market will result in a shortage of
prescription drugs in Canada. Several Canadian medical organizations, such as the
College of Physicians and Surgeons of Alberta and the Canadian Medical Protective
Association (CMPA), advised members against co-signing American prescriptions, under
threat of disciplinary action (Gregoire, 2003). The Association provides an example that
if an American consumer files a lawsuit against a Canadian pharmacist, the Association
could not defend the member against U.S. litigation. Canadian consumers also face
ramifications due to the growth of these pharmacies.
This cross-border market is viewed with trepidation by some Canadian researchers
and legislators. Canada NewsWire quotes a research analysis conducted by Pangea
Consultants (a health care industry specialist firm), which indicates American health care
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needs are so vast that Canada would be unable to meet the U.S. demand, and that
attempting to meet U.S. needs would adversely affect Canada’s health care system. The
research states that an increase in cross-border sales could have the following adverse
affects on Canada: (a) retail drug shortages among Canadian pharmacies, (b) drug price
inflation in Canada, (c) pharmacist shortage because of diversion to U.S. patient care
(“New mood,” 2004). Statistics by IMS Health Canada show a large increase in cross-
border online sales from 2002 to 2003 among the various Canadian provinces, and states
that Manitoba ships 45.5% of its total top 10 drug classes to the U.S. The agency raised
the concern that because these drugs are the ones most sought by both countries,
Canadian patients could be placed in direct competition with U.S. consumers for these
drugs (“Manitoba still tops,” 2004).
In the most recent round of the dispute, Canadian Health Minister Ujjal Dosanjh
stated that, “The practice by some doctors of counter-signing prescriptions without
actually having a relationship with the patient and properly assessing the patient is
absolutely unethical and unprofessional” (Krauss, 2004, p. A1). Even more emphatically,
Dosanjh declared, “Canada cannot be the drugstore of the United States” (p. A1).
Besides Canadian industry groups’ apprehension, members of the Canadian
government have also expressed concern about the rise of mail-order pharmacies and the
impact on Canadian consumers. In November 2003, Senator Robertson of the Canadian
Senate (C-NB) reviewed Internet pharmacy risks posed by Canadian pharmacy and
medical associations about the safety impact of this border, and concerns about the drug
supply for Canadian consumers (Canada Parliament, Senate, 2003).
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Although some Canadian lawmakers and healthcare associations have expressed
unease with the growth of Canadian online pharmacy sales to U.S. consumers, other
Canadian authorities have encouraged this practice after recognizing growth and profit
potential. Whitwham (2003b) stated that in 2003, “Manitoba began issuing licenses to
online pharmacies, authorizing them to sell to international customers” (p. 1033). He also
quoted Ron Guse, registrar for Manitoba’s pharmacists, who claims certain pharmacies
are writing prescriptions for U.S. customers without reviewing the medical background
of the patient.
Online Canadian pharmacists claim that they will ultimately prevail over their
opponents. Krauss (2004) noted that online Canadian pharmacies sales are still increasing
albeit at a much slower pace. In addition, some of the biggest companies are making
radical changes in their business plans. Ironically, some of the plans include moving the
pharmacies to locales outside of either Canadian or U.S. jurisdiction, a move that could
expose consumers to far greater risks than the purchase of re-imported, U.S.-
manufactured drugs.
With an increase in the number of uninsured U.S. citizens and rising health-care
and pharmaceutical costs, consumers are concerned about the availability of affordable
drugs. Korcok (2002) indicates politicians have promised consumers greater privacy
regulations, access to cheaper drugs from Canada, and the right to sue HMOs, although
none of these has been fulfilled. Because of consumer frustration, many constituents are
turning to voting for receptive congressional representatives as a way to contain medical
costs and to ensure that the FDA does not enforce laws preventing them from importing
drugs from Canada. Korcok (2002) quotes a study of the American Association of
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Retired Persons (AARP) showing that 26% of retirees would vote against any senator
who prevents passage of legislation mandating a prescription drug benefit. A 2003 ABC
News-Washington Post poll indicated that 70% of U.S. respondents believed that it
should be legal for consumers to buy prescription drugs outside the U.S. One in eight
respondents said they or someone in their household had done so (“Poll: Public
supports,” 2003).
In a survey conducted in October 2003, 77% of Americans deemed it
“unreasonable” for pharmaceutical companies to prevent Canadian pharmacies from
selling prescription drugs to Americans online (Cohen, 2004). An estimated 35% of
Medicare recipients lack prescription drug benefits and some 22% of seniors are unable
to fulfill prescriptions due to the high cost or skip doses to make a prescription last
longer. In view of these circumstances, Cohen notes that, “even breaching the law can
appear justifiable” (p. 16).
One can argue that virtually all the laws governing Internet privacy and commerce
are in a state of flux. Existing laws are inadequate for addressing the challenges of
conducting business on the Internet. As more consumers utilize online firms for
purchases of all types, they still express numerous concerns related to the protection of
personal information on the Web.
Privacy Practices and Consumer Behavior: Empirical Research
Internet Privacy Practices
Leizerov (2001) conducted a comprehensive investigation of the consumer
privacy practices of 145 Web sites randomly selected to represent several industries and
categories. These included: (a) Web sites offering computers and Internet products and
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services, (b) Web sites providing news information, (c) Web sites providing travel
information and services, (d) Web sites providing health information and related
products, (e) Retail sites selling consumer products that did not fall into any other
category, (f) Entertainment and sports, including videogames and sports, and (g) Portals,
including sites such as Yahoo! that provide online information only, a search engine,
personalized services, and e-mail service. The Web sites were examined according to
their compliance with and attitudes toward privacy regulations, intrusiveness of data
collection, integrity through ethical privacy practices, and transparency and
accountability.
Leizarov (2001) found that economics had a significant impact on Internet
privacy practices. Online firms whose existence depended on a strong commercial
relationship with Internet users showed the most responsible privacy practices.
Alternatively, portals are primarily dependent on advertisers and marketing partners for
their success (and thus stand to benefit from collecting more data about customers’
interests, preferences, and demographics). Moreover, they are usually further removed
from the consumers and also had the most lax attitude about privacy protection.
The online firms’ understanding of the need for policies that respect consumers’
privacy preferences is an extension of the trust that is essential to all business, regardless
of whether they are online or on-ground (Hosmer, 1995). Online businesses that also run
brick-and-mortar operations showed significantly more respect for trust building
practices than those whose presence was exclusively online. However, Leizerov (2001)
proposed this might be due to most of the e-businesses being young companies at the
time, as Internet technology is relatively new. Online businesses such as Amazon.com
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have had time to develop more expertise in establishing positive consumer relationships.
Leizerov also found that Web sites in the “Computers and Internet” category also had
high scores on compliance with privacy rules and trust building practices, second only to
traditional retailers with an online presence. This applied not only to companies selling
expensive items but also to Web sites that offered product reviews and free software
downloads. Leizerov suggested the practices reflected recognition that their sites attracted
savvy Internet users with knowledge of how to protect their privacy online.
Privacy Seals
Privacy usage seals are available to Web sites through programs where “trusted”
organizations certify that Web sites meet strict privacy usage for the information
collected from their customers. The seals represent visible efforts by online organizations
to demonstrate that they protect consumer privacy through self-regulation (Bahadur,
Chan, & Weber, 2002). BBBOnLine and TRUSTe are probably the best known of the
privacy seal organizations. TRUSTe has two major seal program options relevant to
online pharmacy businesses: the Privacy Seal Program and the E-Health Seal Program
(TRUSTe, 2004). The Better Business Bureau runs another popular seal program, BBB.
They have two programs that e-commerce sites can use to address consumer privacy
concerns, the reliability seal program and the privacy seal program. The reliability
program requires businesses to abide by BBBOnLine’s Code of Online Business
Practices and Code of Advertising. Its privacy seal program requires firms to have stated
online privacy pages, which conform to BBBOnLine’s privacy guidelines (BBBOnLine,
2004).
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Consumer marketing research indicates that the prominent display of a privacy
seal has a significant impact on consumers’ perceptions of trustworthiness (Pennington et
al., 2003). However, there is an important question of whether TRUSTe, BBBOnLine,
WebTrust, or other privacy seal programs have the power to enforce their stated privacy
protection principles (Moores & Dhillon, 2003). Once again, the seals raise the issue of
how to achieve a balance between industry self-regulation and government regulation
while protecting the interests of consumers and vendors.
Leizerov (2001) also reported substantial differences in the practices of Web
operators who were members of BBBOnLine and TRUSTe. Namely, “TRUSTe, which
depends economically on the fees paid by its members was found to be significantly less
rigorous in monitoring them when compared to BBBOnLine” (pp. 230-231). He observed
that on some measures, Web sites that were not part of any seal program fared better than
members of TRUSTe. Economic factors proved to be the overriding predictor of privacy
and trust building practices, as evidenced by both the high scores of the online retailers
and the lower monitoring efforts of the fee-based TRUSTe.
Although seal programs could alleviate some consumer privacy concerns, the
literature indicates that they are not without controversy. Larson et al. (2003) states that
although firms have set up seal programs to address consumers’ privacy trepidation, these
programs are self-regulated and depend on member self-compliance. Larson notes that
another problem is that consumers could become confused because each program treats
Web sites in a slightly different manner. Moores and Dhillon (2003) validated Larson’s
research. Their study analyzed three privacy seal programs: TRUSTe, WebTrust, and
BBBOnLine by reviewing the posted features of each of the sites including what
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information is collected, how the information is collected, opt-in options, complaint
procedures, feedback from the online community, the number of recipients in each
program, the review process, and the fees to use the program. The results indicated that
all three organizations have similar principles on data collection, feedback, and security.
However, procedures are different for each firm, and could be a factor for consumers to
consider when placing their trust in a program.
Even when Web sites contain these third-party approval seals, consumers may be
ambivalent towards placing great faith in them. Brown (2002) cites a Pew Internet &
American Life study, which indicates few people bother to determine if a site’s privacy
policy has been independently checked by a third party, such as a privacy seal program.
Fair Information Practices
When online firms include a privacy page on their Web site, the overall policy can
contain a variety of selections. While there can be numerous policy segments, the overall
policy should adhere to general practices. The U.S. Federal Trade Commission (2000)
issued a Fair Information Practices report to Congress in May 2000. The Commission
recommended that commercial Web sites that collect personal information comply with
four Fair Information Practices: (a) notice, where Web sites should provide consumers
with understandable notice of their privacy and information practices, including what
information they collect; (b) choice, where Web sites should offer customers options on
how their information will be used, as well as how that information is disclosed; (c)
access, where Web sites should allow consumers access to their data as well as
opportunities to correct inaccurate information; and (d) security, where Web sites should
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take reasonable steps to protect personal consumer information (U.S. Federal Trade
Commission, 2000).
While these four practices are stated in general terms, the specific policies and
practices for each site depend on the technical and business procedures of the firm.
Numerous explicit policies incorporate the functionality of the four fair information
practices. However, even with inclusion of fair practice principles, consumers may find
privacy policies too complicated to understand. FTC Commissioner Sheila Anthony
believes online privacy policies are too difficult for consumers to locate and contain too
much complex legal jargon for the average person to understand. She believes
“companies need to standardize their policies in much the same way that food companies
use nutrition labels that make it easy for consumers to count calories” (Thibodeau, 2001).
Cadogan (2001) conducted a case study of the incorporation of Fair Information
Practice Principles in the privacy policies of three well-known Internet and distinct
Internet entities: Amazon.com, Dell, and the Privacy Alliance. Amazon and Dell both
store cookies that enable them to maintain a profile of their customers. Cookies are small
text files placed on a user’s computer by a site that wishes to collect information or to
assist the user in site navigation. Using cookies allows online firms to individualize their
marketing techniques (Amazon’s customer recommendations are a notable example), a
convenience to both marketer and consumer. Both Amazon and Dell also offer customers
the option of receiving emails to inform them of updates, complementary products, and
sometimes, special offers to previous buyers. Cadogan noted that the predominate
preference of online merchants is the opt-out strategy (asking to be removed from
notification lists) versus opt in (having to request to be on a notification list).
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Direct and Indirect Data Collection Methods
Online customer information can be accumulated two ways, directly and
indirectly. Data can be collected directly from consumers who enter their information via
forms or email on the business’s Web site. Indirect collection is a method used to gather
data through a secondary source. Normally, consumers enter their personal information
on a variety of sites. Indirect collection software systems were created to alleviate the
burden of remembering a variety of personal data to log into each site. Microsoft’s
Passport profile is an example of indirect collection. A consumer’s personal information,
such as password and credit card number, is stored in a centralized database. Then,
instead of signing onto various sites, the consumer merely references the centralized
profile in order to access any Web site they normally use. Although methods, such as
Microsoft’s Passport, can reduce the number of times consumers enter personal data, they
are not without problems. Regan (2003) states that in 2003 a serious flaw was discovered
in the software that could have compromised consumers’ privacy data. In 2002, the FTC
found that Microsoft was making false claims for privacy and security with this software
(U.S. Federal Trade Commission, 2002c). With security issues related to Microsoft’s
products a concern within the Internet community, consumers may believe that their
personal information is better protected when collected through direct means.
Medical Data
In order to fulfill prescriptions, licensed online pharmacies may require their
customers to divulge medical history. The online firms may also provide advice on the
prescription order, as well guidance on medical issues. Although consumers need timely
and accurate access to drug information if they use these sites, accurate data is not
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necessarily provided. A 2001 study of 104 e-Pharmacy Web sites by Bessell, Anderson,
Silagy, Samsom, and Hiller (2003) found that consumers who self-select medicines from
online sites have insufficient access to information when ordering their prescriptions, as
well as limited information about how to use the products safely and appropriately. This
was one of the first studies that evaluated the quality of information published on online
pharmacy Web sites and indicated that sites often provided low-quality information both
on the sites and well as insufficient information in the packaging. One of the underlying
factors relating to potentially harmful effects of using the products was inadequate
exchange of information between the site and patients. The authors stated that the
medical history and personal information the sites collected, such as current medications
the consumer was taking, was often insufficient to safeguard against adverse drug
interactions.
Cookie Usage and Web Bugs
Cookies have benefits to both online firms and their users. Sites can use
information for marketing purposes, such as surfing habits. Consumers use them for
faster site navigation, such as when login information is saved for quicker logins.
However, consumers fear too much personal information can end up in a firm’s database
from such protocols, especially when they never gave explicit consent for firms to gather
this data.
When privacy standards for cookies were being created, the FTC and several
subgroups of the Internet Engineering Task Force (IETF) standardization committee
disagreed over the privacy principles to be included in cookie standards (Kristol, 2001).
Although Kristol claims that better privacy features could have been applied to the
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original cookie project, such recommendations could be applied to new standards projects
to offer better privacy protection for consumers when using cookies. He recommends
future projects address concerns related to the full range of cookie users such as browser
representatives and Web site marketers and operators. New standards efforts cannot be
the sole means to solve cookie issues, voluntary self-regulation programs may also need
to be implemented.
Olsen (2000) mentions that cookies can also be combined with Web bugs (clear
gifs) to identify personal information such as a phone number and address, as well as to
monitor surfing habits without a person’s knowledge. He indicates these bugs serve as
electronic tags and send information back to a marketer’s server, thus keeping personal
tracking information about an individual’s surfing habits. Not only could this combined
technology be used to gather demographic information, it is conceivable that personal
medical information could be gathered, along with a consumer’s surfing habits of the
online pharmacy and related medical information sites. Although there are concerns with
private industry collecting information from cookies, the practice transcends this arena,
and extends to government sites. A study by Bahadur et al. (2002) reviewed U.S.
government problems with controlling cookies and Web bugs on government sites.
Although the government has prohibited cookies from their sites since 2000, the audit
found that 23 government sites had 300 cookies on various pages and 23 Department of
Commerce pages had Web bugs (Bahadur et al., 2002). Clearly, although laws may exist
to protect consumers, they are not always observed.
Because there are benefits to cookies, Leizerov (2001) does not recommend that
users turn off the ability to accept all cookies. Instead, he states that enhanced privacy
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may be augmented by setting attributes on their Internet browsers to reject cookies that
do not bear the name of the domain they visit.
Profiling Information
Web developers use cookies to collect a variety of marketing and other
information stored on a person’s computer. This information can be used for personal
profiling and data mining. This profiling information can include Internet Protocol (IP)
address, browser types, referring Web site address, log files, usage tracking, and domain
name. Cadogan (2002) states that online firms can use this data to track consumers’
online movements and actions, and businesses can use this information to create targeted
advertisements.
Information Update Policy
Consumers possess two primary methods to control personal information from
being divulged to online sites. First, they may have the ability to request that the online
business updates incorrect information. Second, they may be able to request that their
data be deleted from the information database. A study of 21 health-related sites by
California HealthCare Foundation found that only 10 sites allowed users to correct
information collected voluntarily (Goldman, Hudson, & Smith, 2000).
Under HIPAA, medical Web sites defined as “covered entities” are required to
comply with the privacy regulations. These regulations provide consumers with the right
to see, copy, and correct their health information at online sites, and the firms are
required to respond to users’ requests by a specific deadline (Choy et al., 2001). Although
online pharmacy consumers who wish to update their online data may assume they are
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covered under HIPAA, this may not necessarily be the case. Online pharmacies are not
specifically defined as “covered entities” under HIPAA. Although consumers may value
the ability to view and update their information in a positive light, this protection may not
be mandated for some online pharmacy sites. The ability to update consumer information
is not legally mandated across all types of online business sites.
Disclosure to Third-Parties
Not only do primary sites collect personal data about the consumer, but it is also
possible that those firms share this information with third-party firms or affiliates. In
order to observe principles concerning informed notice of the Fair Information Practices
ideals, it is important for consumers to understand where their information is being
disseminated. A study by the California HealthCare Foundation of 11 online medical
sites with third-party networks showed that only five of these sites stated that third-party
networks were able to collect information about users (Goldman et al., 2000). This may
lead to the consequence of a firm sharing data with an affiliate firm unknown to the
consumer.
Online firms may use a wide variety of idioms to describe their relationship with
third-party firms, and may include various “relationship” terms in their privacy policies.
These various terms may confuse consumers who may question the strength of the
relationship and data sharing among the firms. For example, the term “affiliate” could be
interpreted broadly to mean any type of general partnership between two firms. The use
of general terminology relating to disclosure by third parties is common. Goldman et al.,
(2000) found that although the Web sites in their study were likely to notify users about
information disclosure, they included broad statements about such disclosures.
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Security
Online firms often face a dilemma when posting detailed security elements on
their privacy sites. If they do not post information on the methods they use to secure
customer data, consumers may conclude that the firm does not practice safe computing
and information security practices. However, if they post security policies, in detail,
hackers may use this information as a starting point to gain unauthorized access to the
system. Therefore, firms may maintain a balance of documenting the security of their
systems. They often provide a policy to reassure consumers that security is taken
seriously, but not supply details sufficient to provide ammunition for hackers to bypass
security controls. The Online Privacy Alliance, a self-regulatory group promoting privacy
policies for private sector Web sites, provides general guidelines for firms to follow when
dealing with privacy issues: (a) sites should take appropriate measures to ensure the
reliability of consumers’ information and take precautions to safeguard it, (b) sites should
take reasonable steps to ensure that affiliates and third parties who share this data are
aware of their security practices and these associated firms also engage in safe security
practices (Privacyalliance.org, 2003a).
Although there is concern among consumers as to the safety of their data being
held in corporate databases, it is to the advantage of firms to ensure the data is secure.
According to Cadogan (2002), firms have invested so much time and money to develop
systems and collect personal and marketing information on Internet users, it is imperative
they develop safe and secure systems to prevent hackers and other unauthorized people
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from stealing the data. Data has value, and it is in the best interest of firms to develop
adequate security and data control mechanisms.
COPPA Law
The Children’s Online Privacy Protection Act (COPPA), enacted in 1998, is
intended to prevent the online collection of personally identifiable data from children
under age 13. The U.S. Federal Trade Commission (1999) has issued basic rules on what
online businesses must do to comply with this regulation. In general, the FTC states that
if a site directs service to children under 13 or knowingly collects knowledge about
children under 13, they must comply with the law and must post a privacy notice and
receive verifiable parental consent to collect a child’s information. This legislation would
affect any online Internet pharmacies that dispense information to underage children.
In April 2001, the FTC (U.S. Federal Trade Commission, 2002b) surveyed 144
Web sites directed at children 12 and under. The survey showed that 72% of the sites
collected personal information online, such as the child’s full name and email address.
The study came to two conclusions about the state of Web sites following COPPA law.
First, most sites are complying with the requirement that they identify to the user that
they are collecting children’s personal information. Second, other COPPA specifications
are not followed consistently, such as compliance with how this information is used (U.S.
Federal Trade Commission, 2002b).
Changes to Policies
Online Web firms may notify consumers of changes to their privacy policies. In
order to alert consumers, a caveat within the policy page indicates a policy may change
54
and that notices to specific changes to the policy are available on the Web site. Many
leading firms have posted changes to their sites notifying consumers of changes. Hu
(2003) provides two examples of prominent firms posting changes to their policies,
Disney and Yahoo. Disney changed its privacy policy in late 2003 to allow sharing of
customer information with outside firms. Customers now must take the initiative to opt-
out of this sharing provision.
Pharmacy Licensing and Written Prescriptions
One factor online consumers can use to evaluate the authenticity of both Canadian
and U.S. Internet pharmacies is whether the pharmacy holds a valid license. However,
before customers review the privacy policies and licenses, they must understand the type
of online firms with which they are dealing. According to PharmacyChecker.com
(2003d), there are two types of online pharmaceutical firms, pharmacies associated with
brick and mortar firms, and pharmacy intermediaries. The latter type merely serves to fill
orders through an associated pharmacy. PharmacyChecker.com (2003d) states that U.S.
firms are required to be licensed in the state to which they ship their products. This makes
it easier for consumers to take legal action if they encounter troubles. However, because
drugs purchased through U.S. online sites are considered expensive, consumers are
flocking to Canadian-based online pharmacies and intermediaries. According to studies
by the U.S. Congress House of Representatives Government Reform Committee, U.S.
citizens pay an average of twice as much for the same prescription drugs as citizens in
other countries, and can pay up to 10 times more for certain drugs (U.S. Congress, House,
2003).
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Those consumers who utilize specific Canadian pharmacies may enjoy a higher
level of protection when investigating if a site has a valid license. In 1999, the National
Association of Boards of Pharmacy (NABP) in Canada created the Verified Internet
Pharmacy Practice Sites (VIPPS) program to provide consumers with the ability to use a
single source to check a pharmacy’s certification (National Association of Boards and
Pharmacy, 2004). The VIPPS program certifies pharmacy sites as having legitimate
licenses and as having undergone a certification process. If an online site has a VIPPS
certification icon on its site, consumers have a way to verify licensing. However, as of
January 2004, only 14 pharmacies, mostly large national U.S. pharmacy chains, meet the
VIPPS qualifications, compared to the myriad of current Canadian online pharmacies
(National Association of Boards and Pharmacy, 2004).
Another issue to consider is whether the site requires a written prescription from a
physician. Although Canadian law states that physicians must sign Canadian
prescriptions, the standards for pharmacists in each province differ, which can lead to the
possibility of online pharmacies bypassing professional standards (Whitwham, 2003a, p.
759).
Opt-in and Opt-out Strategies
Cadogan (2001) proposed that an opt-out strategy might be better for merchants
and consumers than opt in. “This would permit businesses to better target consumers,
while individuals would be better enabled to avoid invasion of their privacy” (p. 327).
However, she conceded that many sources consider this impractical, expensive for
businesses, and oblivious to the fact that consumers are opting in even before they make a
purchase, either by filling out information forms or simply by visiting the site.
56
Cadogan’s (2001) strongest recommendation is that consumers need
comprehensive and accurate information if they desire to protect their privacy. She
recommends that consumers gain knowledge of security and technical issues as well as
marketing and technical issues. Lee (2002) shares a similar perspective. Both authors
recommend providing information to the public that covers technical issues related to
privacy but is easy for the layperson to comprehend. They also note that online privacy is
a global issue, thus a more uniform privacy program would be the most practical
approach. In fact, Cadogan (2001) suggests pressure from the European Union will
inevitably lead to more uniform international privacy policies. Cadogan also argues that
online businesses have a large stake in upholding the privacy wishes of consumers for
two key reasons. The first is the issue of winning consumer trust. A second reason is that
complaints about privacy abuses could lead to government regulations that fail to
consider the dynamic nature of cyberspace and thus have the counterproductive effect of
stifling Internet commerce. If Internet firms do not police themselves and provide strong
privacy, then legislation may be passed that would benefit consumers, but may not be
friendly to online firms.
A 2001 survey on the privacy policies and practices of commercial Web sites
synthesized data from the 85 busiest Web sites (“most popular”), a random sample of all
sites with more than 39,000 unique visitors, and a subset of the random sample that
focused on the top 5,625 sites (Adkinson et al., 2002). The study marked the fourth in a
series of research projects beginning in 1998. The 2001 study found that Web sites were
gathering less information than they had two years earlier, showing a steady rate of
decline. The researchers also observed fewer Web sites with third party cookies, dropping
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to 48% from 78% for the most popular sites and to 25% from 57% for the random
sample. Consistent with this trend, they also noted that privacy notices were more
prevalent and more prominently displayed. Virtually all the most popular sites and 83%
of the random sample had privacy notices, roughly the same as for 2000. While the
privacy notices tended to be more easily accessible, they were lengthier.
An interesting change was the reversal of Cadogan’s (2001) finding that opt-out
policies were more prevalent than opt-in policies. In the sites included in both the most
popular category and the random sample, Adkinson et al. (2002) reported a marked
decline in the number of Web sites with opt-out polices and a marked preference for opt-
in policies. The researchers also found more sites offering a better combination of fair
information practice components. The only finding that did not appear to differ
substantially from the previous study was the use of P3P enabled browsers and privacy
seals. The use of privacy seals clearly lagged far beyond other privacy protection
practices.
At the time of the study, P3P technology had only been available for a short time.
However, Adkinson et al. (2002) noted that 25% of the most popular Web sites and 5%
of the random sample had implemented the protocol, which they considered a good start.
The World Wide Web Consortium (W3C) Platform for Privacy Preferences (P3P) is a
standardized method that enables Web sites to encode their privacy policies in a
computer readable format (W3C, 2003). P3P was in the development stage for several
years, and the development of the technology has been controversial (Hochheiser, 2002).
Flammia (2000) proposed that, “If most Web sites agree to publish privacy
policies and seals of approval in machine-readable format, they pave the way for
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distributed intelligent agents that could act on our behalf and protect our privacy.”
Although somewhat ambivalent about the thought of “distributed intelligent agents”
protecting consumer privacy, Flammia noted that it would shift the burden of scrutinizing
privacy protection from the consumer to the technology (p.13). Hochheiser (2002) refers
to P3P as a “social protocol,” which has been criticized as a mechanism that allows
online business to escape meaningful legislation. The W3C counters that the purpose of
P3P technology is providing consumers with more control over their personal data (W3C,
2003). Depending on one’s perspective the rapid adoption of P3P technology by Internet
sites, particularly the most heavily trafficked, may either be construed as evidence that
Web businesses are responding to consumer demands for control over their personal data
or attempting to avoid additional regulation. The findings reported by Adkinson et al.
(2002) suggest that Web businesses are responding to consumers’ privacy preferences.
According to W3C (2002), about 25% of the top 100 Web sites have adopted P3P.
However, adoption since 2002 had slowed due to the state of the economy and
downsizing of privacy staff.
Consumer Behavior
There is a dichotomy between consumers expressing a desire for tight privacy
policies, yet still utilizing online firms that do not adhere to these ideals. Several studies
have validated this discrepancy in consumers’ privacy desires not matching their
behavior when deciding whether to use the sites.
Hsu (2003) conducted a cross-cultural study of Internet privacy issues that
encompassed regulations, Web site privacy statements, and the attitudes of consumers in
China, the Netherlands, Taiwan, and the U.S. An intriguing finding was that there seemed
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to be little connection between consumers’ concern for privacy and their personal
practices. He found that even if customers are significantly concerned about the privacy
of their personal data on a specific Web site, they will still disclose large amounts of
personal information. Although the participants from the two Asian countries reported
more concern with privacy than those from the two Western countries, the Chinese and
Taiwanese subjects disclosed more information than their Western counterparts. Another
interesting point of the study was that out of 400 respondents, only nine clicked on the
Web sites’ privacy policies.
The context of the Web site emerged as an important factor in consumer’s
decision to disclose information. The Taiwanese and Chinese respondents placed their
greatest trust in government sites and the Dutch respondents disclosed a substantial
amount of information to government Web sites (Hsu, 2003). For the Americans, the
pattern showed that they were most cautious about disclosing information to government
Web sites but gave far more information to commercial Web sites than respondents from
any of the other three countries. Both Asian samples gave more information to
community Web sites than either Western group. All the respondent groups kept health
information private although Hsu noted that health information was irrelevant to the sites
visited. Therefore, disclosing health information, as with other information, would be
largely a factor of culture and context. This study also showed that consumer practices
are dynamic and change depending on a myriad of factors, including demographics of the
user, the type of Internet site, and governmental involvement in privacy issues.
A second study by Earp and Baumer (2003) corroborates Hsu’s observations.
They surveyed 415 consumers about their opinions of 1 of 30 Web sites. These sites were
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equally divided among retail, financial, and health/medical sectors. Each category
contained 15 well-known and 15 lesser-known Web sites. The participants were asked
what types of information (demographic, personal, medical, and financial) they were
willing to disclose to the sites. In general, the participants were most willing to disclose
age and gender and least willing to reveal their social security numbers. They were least
reluctant to provide personal information to health sites, followed by financial sites, and
least of all to retail sites. The respondents expressed greatest reluctance to providing
personal information to unfamiliar sites. They also inferred that consumers are more
willing to trust well-known sites because of perceived legal protection of their
information on these familiar sites.
Earp and Baumer (2003) found some differences when they compared the
responses of subjects aged 15-35 and those over age 35. The younger respondents were
more prone to provide their name, age, and gender; to read the Web site’s privacy policy;
and to provide information in exchange for material incentives. The older respondents
were more apprehensive about identity theft, losing control of their information,
unauthorized dissemination of personal information, and exposure to dishonest people.
These differences suggest that both age groups were aware that their privacy could be
compromised on the Web. However, the younger respondents were savvier about privacy
policies, which enabled them to reveal information more comfortably. However, the older
respondents seemed to have more of a global distrust of disclosing information online.
These studies indicate that online users have conflicting emotions and practices
between their views on privacy versus their actual usage of the sites. Although consumers
express a strong desire for online firms to protect their privacy, other factors can
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overwhelm their desire for information protection. Some factors depend on the
consumers themselves, such as upbringing and age. In short, Hsu (2003) found privacy
concerns do not translate to comparable actual practices for consumers.
Consumers recognize that in order to obtain shopping convenience and cost
savings, they may be required to sacrifice a level of privacy. J. Howard Beales, Director
of the FTC’s Bureau of Consumer Protection indicates that consumers recognize these
trade-offs in the commercial arena. He states that consumers are willing to make
compromises between absolute privacy and economic benefits (U.S. Federal Trade
Commission, 2004). Consumers may also view other factors on online sites as more
important than privacy policies. Cost savings, proper licensing, and comprehensive
prescription information may constitute a trade-off to an effective privacy policy. It is
important to review these other factors to determine a customer’s willingness to utilize a
site.
Health Information on the Web
Privacy Policies
In view of the record amounts of information consumers are providing to health-
related Web sites, the California Healthcare Foundation conducted a survey of privacy
policies and practices of 21 heavily trafficked health-related Internet sites (Goldman et
al., 2000). The sites represented a spectrum of categories: sites where consumers’ wishes
for privacy might be more important, sites where consumers were researching and
purchasing health products and pharmaceuticals, general search engines or portals with
substantial Internet traffic, and sites targeting a specific demographic. The study was
conducted in two ways. First, the researchers reviewed sites’ stated privacy policies
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against a set of “fair information practice principles,” which were previously explained in
the Fair Information Practices section of this study. Second, the researchers played the
role of a typical visitor to each site to observe and capture the information they submitted.
The study reviewed privacy policies on these sites and compared their written policies to
their practices.
Even when online firms include privacy policies on their Web sites, the features
in the policies differ widely among firms, and they may not adequately protect user data.
Goldman et al. (2000) reported several findings, some ubiquitous to the Internet and
others specific to health-related sites. The first is a problem across the Internet: users are
unaware that their personal data is being collected and their visits to Web sites are not
anonymous and are tracked. Using mechanisms such as cookies, profiling, and banner
ads, firms can gather information about consumers and their surfing habits. Second, most
sites adhered only nominally to fair information practices. Although most of the studied
sites posted privacy policies, few did an adequate job of safeguarding users’ personal
healthcare information. Few met adequate privacy criteria such as providing sufficient
notice, providing users with control over their information, and holding business partners
to the same standards of privacy. Thus, it is not surprising that the researchers observed
discrepancies between the privacy policies of the health sites and their practices. A
common practice included collecting personal information via cookies and banner
advertisements by third parties without indication by the host sites. Few of the sites had a
partnership in which third parties were held to the same privacy standards as the host site.
Goldman et al. (2000) also noted instances involving the transfer of personal information
of third parties in explicit violation of privacy policies.
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Failure to disclose collecting personal data through cookies and banner ads and
transferring personal data to third parties in violation of privacy policies were two of the
primary problems Goldman et al. (2000) found on the health-related Internet sites. A
third problem was inadequate security that raised the risk of unauthorized access to
visitors’ personal data. Goldman et al. (2000) acknowledged that given the rapidly
changing nature of the Internet their findings are probably subject to change over time (in
fact, several of the Web sites no longer exist). However, their recommendations to
Internet health sites are equally valid today. They recommended that health sites make
greater attempts to provide visitors with anonymity, close the gap between their privacy
policies and practices, and of particular note, work collaboratively to develop a model
privacy policy for Internet health sites.
Consumer Attitudes and Behavior
The Pew Internet & American Life Project, a nonprofit initiative dedicated to
researching the impact of the Internet on various aspects of American life, conducted a
series of studies in early 2000 related to consumer use of health-related Web sites and the
consumers’ attitudes toward privacy issues. The samples were derived from the larger
study of Internet use. For the first exploration of health seeking on the Web, the
researchers contacted 2,109 adults, including 1,101, who were Internet users (Fox &
Rainie, 2000). A sub-sample of this group consisted of 521 Internet users who sought
health information online.
Fox and Rainie (2000) found a small percentage of adults who used the Internet
for consulting a physician or purchasing medications or vitamins online. Of this sample,
17% had given their name or other personal information to a health site and 21% had
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provided their email address. More than half (54%) had gone online on behalf of
someone else on their last health site excursion, including children, parents, other
relatives, or friends; only 43% said they had visited the site for themselves. A majority
was seeking information about an immediate medical problem, primarily in conjunction
with a doctor’s visit. The vast majority (93%) appreciated that they could get information
on the Web at their convenience. Most agreed that the Web offered more health
information than they could find anywhere else (83%). A similar proportion cited
anonymity as important (80%), and 16% of respondents said they used the Internet for
information dealing with a sensitive health issue about which they found it difficult to
talk.
The preference for anonymity was accompanied by apprehension about privacy
breaches on the Web (Fox & Rainie, 2000). The overwhelming majority of respondents
(89%) were concerned that an online site might sell or give away information about their
visit; 71% said they were “very concerned.” A major concern was that they might be
denied insurance coverage or have their insurance rates increased because of the health
sites they browsed (85%), with 72% describing themselves as “very concerned.” Slightly
more than half (52%) were afraid their employers might find out (this concern was less
prevalent since most respondents were going online at home). The respondents were
divided over the merit of putting medical records on the Internet, although a majority of
health seekers (63%) as well as Internet users in general (60%) thought it was a bad idea.
They were concerned about people gaining access to their personal medical files even on
a secure, password-protected site. The rest of the sample favored putting medical
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information online because it made it easy for them and their doctors to access the
information.
Demographically, Fox and Rainie (2000) found a higher proportion of women
than men using the Internet for health information (63% versus 46%, respectively).
Neither income nor ethnicity predicted use of the Web for health information, in contrast
to findings from research on other online activities. The highest proportions of health
seekers fell into age categories between 30 and 64. Internet experience had some effect
on seeking health information online, although the researchers noted the difference
between novices and experienced Internet users was smaller than for most online
activities.
Almost half the respondents who sought medical information online (48%)
reported the information they found on the Internet helped them to take care of
themselves and 55% said the Internet offered a better way to gain health information.
However, Fox and Rainie (2000) noted that most were concerned about the legitimacy of
the source. Among all Internet users, whether or not they sought medical information
online, 82% were concerned about getting unreliable health information online. As a
result, 58% were careful to check the name of the organization providing advice on a
health-related Web site. This practice was more prevalent among respondents who had at
least some college education.
Overall, the findings of the 2000 Pew study (Fox & Rainie, 2000) showed both
caution and concern. Despite apprehensions about privacy breaches, and to a lesser extent
unreliable information, Internet users welcomed the ease of access to health information
offered on the Web and roughly one-half reported positive health benefits.
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A subsequent Pew study delved into the privacy concerns expressed by the
overwhelming majority of respondents. The researchers noted that there is a double-edge
to both paper-based and electronic medical databases (Choy et al., 2001). The tasks
involved in locating and distributing paper files limit the chances that the data will reach
unauthorized sources but may also limit information access and sharing by legitimate
stakeholders. The concerns over electronic data files are exactly opposite. Information is
easy to obtain for legitimate purposes but the ease of access raises the risk of
unauthorized use.
Choy et al. (2001) addressed the extent to which the activities of Internet health
sites fall under the jurisdiction of HIPAA. Generally, HIPAA applies only to three health
care entities: health care providers, health plans, and health care clearinghouses. This
limitation excludes many health-related Web sites. Thus, depending on who owns or
operates the Web site, a site offering the same services may or may not fall under the
heading of a “covered entity.” The Pew study examined the nature of different types of
health sites on the Web and the degree they were covered by HIPAA privacy regulations.
Choy et al. (2001) found a large gray area in the nature of health-related Web sites
that sell multiple services. For example, some Internet sites that dispense health
information also allow patients to review test results online. This latter service falls under
the privacy regulation, while most of the communication on the site probably does not.
Another example is drugstore.com and the online services portions of pharmacies such as
CVS and Walgreens, which sell both prescription drugs and non-prescription items
online. The prescription drugs are protected under the privacy policy; the other items are
not. Choy et al. (2001) suggest that posting privacy practices may complicate the privacy
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issue by confusing consumers and possibly leading consumers to believe all their
transactions are covered under HIPAA. The prevalence of health sites that perform
multiple services highlights the importance of posting a privacy policy that is clear,
accurate, and easily understandable to online consumers.
Internet sites that are entirely under the control of patients are excluded from
privacy regulations. Choy et al. (2001) note that this has the effect of patient-controlled
health sites allowing patients access to information, yet, visitors may be unwittingly
relinquishing control of their health information by providing it to the sites that are
exempt from the policy. There are also Web sites that allow visitors to create their own
medical records online. If they are not owned or operated by covered entities, the privacy
of these records does not fall under federal regulatory oversight.
Overall, the Pew researchers found serious limitations to the extent that health-
related Web sites are covered by regulatory mandates. The HIPAA rule, which covers
only health plans, health care providers, and health clearinghouses “may create an
illusion of legal protection that may lull consumers into a false sense of security when
they engage in online health activities” (Choy et al., 2001, p. 24). The report concluded
that
People often believe they are invisible and anonymous online, but they are often
exposing their most sensitive health information and online health sites that are
not required by law to protect the information or keep it confidential. The
potential for abuse is enormous. (Choy et al., 2001, p. 25)
The 2000 Pew study provided a general picture of U.S. consumers’ reliance on
the Internet for health information. A second study conducted in late 2002 provided a
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more detailed analysis of online health-seeking behaviors. This study involved 2,038
adults, including 1,220 Internet users (Fox & Fallows, 2003). Searching health sites
online proved to be one of the most prevalent online activities. Eighty percent of the
sample, or roughly 93 million U.S. adults, reported searching for information on one of
16 health-related topics. As in the 2000 study (Fox & Rainie, 2000), the largest segment
of health seekers used the Web to find information about a specific medical condition
(63%), followed by researching a particular medical treatment or procedure (47%).
Roughly one-third (34%) of the sample sought information on prescription or over-the-
counter drugs (Fox & Fallows, 2003).
More women (85%) than men (75%) sought health information online (Fox &
Fallow, 2003). However, 80% of the respondents who reported visiting health-related
Internet sites said they did so infrequently (every few months or even less often). Only a
small proportion reported communicating with doctors online or through e-mail, although
those who did regarded it as a convenience. Doctors seemed to have mixed feelings about
seeking health information online; some supported their patients’ online health seeking,
while others advised against it. The authors found that the proportion of respondents who
held high regard for the Internet for improving the health information and services they
received jumped from about 50% in the 2000 survey to 73%. Respondents offered
suggestions for improving access to health resources on the Web although in some cases
the information they sought was already available online, albeit without clear links for
finding it.
Most of the 2002 findings reiterated the results of previous research. However,
despite the increasingly positive attitudes of consumers toward online health resources,
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Fox and Fallows (2003) noted that only a minority followed recommended search
guidelines. Only about one-quarter were meticulous in checking the source and timeliness
of information or verifying the information they found each time they conducted a search.
Another quarter said they checked the source and date of a site’s information “most of the
time”; half did so “only sometimes,” “hardly ever,” or even “never.” In general, the
respondents were largely satisfied with the health resources they found on the Web,
particularly individuals with disabilities or chronic illnesses and those in rural areas
whose Internet access to health information was greatly improved.
The most recent of the Pew studies focused specifically on consumer behavior
regarding prescription drug information. The sample consisted of 2,200 adults, including
1,399 Internet users, interviewed in spring 2004 (Fox, 2004a). The huge market for
prescription drugs was confirmed by the finding that 64% of the households surveyed
consume prescription drugs on a regular basis. However, the proportion of adults who
have searched for prescription drugs online is low; 21% personally conducted a search
and 5% had someone else search for them. The groups most likely to have conducted
prescription drug searches online included individuals with high-speed Internet access at
home and at work, Internet users with six or more years of online experience, college
graduates, and Baby Boomers. The practice was most widespread in the 40-49 year-old
demographic and least common among seniors age 69 or older. Individuals with chronic
illnesses or disabilities were no more predisposed than other groups to search for
prescription drugs online, although Fox (2004a) noted that others might have conducted
such searches for them. While seeking generic health information online cut across all
ethnic backgrounds (Fox & Rainie, 2000), white consumers were about twice as likely to
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seek prescription drug information as blacks or Latinos (24%, 12%, and 14%,
respectively (Fox, 2004a).
In Fox’s study, the respondents displayed considerable skepticism about buying
prescription drugs online; 62% believed it to be less safe than purchasing drugs from a
local pharmacy (Fox, 2004a). Only 20% considered the two venues equally safe. A
substantial majority (68%) agreed with the statement, “Some argue that allowing people
to purchase prescription drugs online makes it too easy to obtain drugs illegally, without
a prescription” (Fox, 2004a). Furthermore, 71% agreed with a statement that people
should not be allowed to purchase prescription medications online because drugs
purchased from pharmacies outside the U.S. lack the safety guarantees of pharmacies
licensed within the U.S.
Fox (2004a) noted that some respondents came from states where legislators
encouraged residents to purchase drugs less expensively from Canadian pharmacies.
Indeed, the report contained Minnesota governor Tim Pawlenty’s famous response to
federal concerns about the safety of Canadian drug imports, “Show me the dead
Canadians” (p. 5). Nonetheless, only 4% of the Pew respondents reported buying
prescription drugs online (3% for personal use and 1% for others). This group included a
small number of non-Internet users. While lower cost is the most widely cited reason for
purchasing drugs online, the practice is more common among consumers that are more
affluent.
The most prevalent reasons for ordering prescription drugs online from both
Canadian and U.S. pharmacies tended to be convenience and time- and cost-efficiency
(Fox, 2004a). A similar majority described themselves as “very satisfied” with the quality
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of the drugs they bought and the customer service they received; about 50% were “very
satisfied” with the price. Not surprisingly, given the high satisfaction, 90% said they
would fill prescriptions online again.
Summary
The quest for lower cost drugs on the Internet by American consumers takes place
in an atmosphere where a large amount of information changes hands on a daily basis.
Consumers have access to information that enables them to take better care of their
health. However, this often comes at the cost of concerns over the privacy protection of
sensitive personal information.
Theoretically, online consumers engage in a cost-benefit analysis, typically
deciding that the convenience, ease, and time- and cost-efficiency of Internet purchasing
justify the potential cost of misuse of personal information. A sizable proportion of
Internet users are unaware that the “anonymity” of cyberspace is an illusion or they are
unaware of the steps they can take to protect their privacy. Over the past two years,
online businesses have decreased the use of third party cookies and sharing consumer
data with business partners, in recognition of the preferences of consumers. These actions
reflect the preference for self-regulation that has historically governed U.S. commerce.
The intense debate over Americans’ purchase of prescription medicines from
online Canadian pharmacies has many unique problems and issues, and it reflects the
larger issues of privacy and trust in Internet commerce. Paradoxically, by limiting
American access to Canadian drugs (which are frequently made in the U.S. and then re-
imported from Canada), the pharmaceutical companies may be raising the risks to
consumers of imported drugs by exposing them to drugs manufactured in countries that
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lack the stringent regulations of Canada and the U.S. Despite the highly charged issue,
however, only a small proportion of U.S. consumers buy prescription medicines online.
Drug quality is one issue cited by prospective consumers. However, the literature to date
suggests that privacy protection is an overarching concern of Internet users, and is likely
to inhibit widespread growth of Internet drug purchases for both Canadian online
pharmacies and legitimate U.S. online pharmacy firms even when it results in
substantially lower cost.
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Chapter 3
Methodology
Introduction
This chapter presents the methods and procedures used to develop the surveys of
privacy polices among Canadian online pharmacies and consumer usage of these sites. A
discussion of the procedures, evaluation tools, and instrumentation will be emphasized.
There are two phases used to develop the evaluation tools. First, a review of specific
privacy factors contained in the online sites was compiled and analyzed. The second
phase was to develop an online survey defining how users of medical Web sites view
Canadian pharmacies. This chapter concludes with a review of the reliability, validity,
and assumptions.
Research Methods Employed
For the initial phase of this study, a systematic review of 25 online Canadian
pharmacies was undertaken. These pharmacies were chosen from two listings. The first
half of the pharmacy list was chosen randomly from Canadian Online Pharmacy
Directory (2004), an online Web site service that aids Americans in locating Canadian
online pharmacies. This is a business directory that lists 127 large Canadian pharmacies
that have paid to be included on a consumer portal Web site. Thirteen pharmacies from
this list were randomly chosen by the researcher. The other portion of the list was
gathered from a search of Google.com. The keywords “Canadian online pharmacy” was
used to search for a variety of these firms, and the second portion of the research list was
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gathered from this query. Although other search terms could have been utilized, these
keywords form a popular basis for the overall conditions of this study. In addition, the
results were chosen from only the search results, not from the results of any sponsored
links. The researcher chose the top 12 pharmacies from this source. From these two
sources, a final list of the 25 Canadian pharmacies was chosen for the study (see
Appendix A).
Based on the pharmacies chosen for this study, an in-depth review of specific
privacy policy pages and procedures followed. Because sites change their pages and
information, privacy information that the reader may review in the future may be
different than the results gathered from this study.
A technical issue encountered in preliminary analysis by the researcher in
assembling this methodology was the dichotomy between the privacy policy information
posted on the site versus the actual practice of the firm. For example, the privacy policy
page might not mention that the site collects customer email or telephone information.
However, a sign-on page on the site could require this information, although this
collection was not specified in the privacy statement. Thus, there was a quandary on
whether to include information collected throughout the site, but not mentioned in the
privacy statement. Due to the scope of this study, the decision was made to concentrate
on information specifically contained within the privacy policy.
The second phase of the study involved an online survey of users of medical Web
sites and their views of Canadian online pharmacies. The audience consisted of
consumers who utilize medical information sites and were willing to take an online
survey. The subjects were recruited from consumers utilizing one of several consumer
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medical sites including (a) DrKoop.com, (b) HealthCentral.com, (c) MDchoice.com and
(d) HealthScout.com. The study analyzed both users and non-users of Canadian online
pharmacy sites, and determined what issues were major factors in why consumers choose
to utilize these firms, including privacy policies, cost, or quality.
There were some issues encountered when picking the medical sites to use for
serving as the portal to the online survey. In order to use a medical site as a portal, a text
link was placed on the medical site as an advertisement. This link invited respondents to
click on the link in order to complete a survey about online Canadian pharmacy usage. A
screen print of one of the advertisement text links on Web site healthcentral.com is found
in Appendix D. A text link to the pharmacy survey is displayed in the middle of the
screen print. When the initial contact was made with representatives of several other
medical sites, such as WebMD.com, the researcher was informed that these sites would
not accept advertisement links for surveys. This research was thus limited to medical sites
that would accept survey advertisement links.
There were several reasons why the four health sites noted above were chosen.
First, all of these sites used the same advertisement firm, GoText.com, to place
advertisements on health-care portal sites. This advertisement firm allowed the researcher
to submit text advertisement links to the Canadian online survey. Second, these health
Web sites are leading distributors of health and medical information to a large number of
Internet visitors. MDchoice.com acquired both HealthScout.com and HealthCentral.com
in 2001, although these three still run independent Web portals. Together, the firms
attract more than 1.5 million visitors each month and are one of the five largest U.S.
online health networks (MDchoice, 2001; HealthCentral.com, 2001). DrKoop.com is
76
named after former U.S. Surgeon General, C. Everett Koop, M.D., and is chairman of the
board of the company operating the site. Prior to filing bankruptcy in December 2001,
DrKoop.com attracted more than 900,000 visitors per month and had a database of more
than 2 million registered users (Cox, 2002). Although the number of visitors has
diminished since the bankruptcy, it still has a sizable audience with an average reach of
60 visitors per million who visit the Web. It ranks 22,903 in most visited Web sites.
HealthScout.com ranks 26,707, HealthCentral.com ranks 14,115, and MDchoice.com
ranks 46,022 as of March 2005 (Alexa Internet, 2005).
The second phase of the project involved a survey of medical sites. The survey
consisted of 44 questions divided into nine specific sections based on the following
criteria (a) demographics, (b) overall privacy policy, (c), consumer/licensing, (d) personal
demographic information, (e) cookies, (f) opt-in/opt-out/update ability, (g) third party
disclosure, (h) security, and (i) miscellaneous.
A Likert scale technique was used to measure participant’s attitudes. Each of the
44 questions was given a ranking on a scale of 1 (strongly disagree) through 5 (strongly
agree). In addition, there was also a “not applicable” ranking for those respondents whose
experience with a question did not constitute a rating. A review of the questions can be
found in Appendix C of this study.
Location of Online Study
The online survey was hosted on a Web site coordinated by
www.hostedsurvey.com. The questions were consolidated into a single Web-based
survey hosted by this firm. Survey results were collected into a database hosted within
this site for further analysis. In order to access this Web-based survey, users clicked on a
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text link that connected them to the questionnaire. A text advertisement marketing group
(GoText.com) handles banner click-throughs for a variety of medical sites. This firm
placed the text links on four consumer medical sites (a) DrKoop.com, (b)
HealthCentral.com, (c) MDchoice.com, and (d) HealthScout.com.
Subjects of Online Study
The first group of subjects (for the initial testing of the survey instrument) was a
group of 10 students recruited from an e-commerce class the researcher was teaching at
St. Petersburg College in Clearwater, Florida. The second group of subjects in this study
were recruited from a random sampling of customers utilizing the four medical sites.
These are sites that specialize in healthcare issues and provide consumers with medical
information. The subjects were expected to be online consumers who have specific health
concerns, and thus would be more inclined to utilize online pharmacies to purchase
prescriptions. Customers of these sites were expected to be adults over 18 years of age,
both men and women. There were 147 responses collected over a two-month period.
Methods and Procedures
For the initial test, approximately 10 students from the aforementioned e-
commerce class were asked to take the survey. The results were used to determine the
validity of the test questions and to ensure that the technology, Web site, and survey
functioned properly. During a regularly scheduled break, the students were asked to
volunteer to take this short survey. The length of time for taking this survey was between
10 and 15 minutes.
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The subjects for the second, main phase were recruited from consumers utilizing
one of several consumer medical sites including DrKoop.com, HealthCentral.com,
MDchoice.com, and HealthScout.com. A text link was placed on each of these sites that
contained a Uniform Resource Locator (URL) where a survey was found on
www.hostedsurvey.com.
Each subject was asked to take a short survey containing 44 questions dealing
with their views and experience with online pharmacy sites. The survey consisted of the
questions found in Appendix C. Survey results were placed in the database for
www.hostedsurvey.com, and was only available by the researcher via an ID and a
password. No other person had access to the individual un-aggregated data, thus ensuring
data security.
Instrumentation Development and Dissemination of Research Instruments
The literature review aided in the development of the research questions to ask in
a survey of sites. The literature was used to first aggregate a number of general privacy
policies that should be contained on any Web site. Then, additional literature was
researched to include privacy policies specific to the online pharmacy industry A
compilation of both general policies and pharmacy-specific guidelines was generated in
order to review them against the policies for 25 major online sites. In addition to the
literature review, Pharmacycheck.com (2003c) conducted a small study of sites for a
limited number of factors when evaluating privacy policies for Canadian online
pharmacies. This research expanded that study to a more comprehensive assessment of
each of the 25 sites chosen for this study.
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Site Surveys
The development process for this study began by compiling a list of privacy
policy procedures that could be contained on a firm's privacy policy site. A list of policies
was compiled and categorized into main sections. Appendix B features a spreadsheet
listing the 25 online Canadian pharmacies on the top columns. The left rows detail main
sections of privacy policy facets that will be further explained in the subsequent sections
of this study. The researcher reviewed the privacy policy on each site to determine which
particular privacy functions were listed on the site. Gaps in the privacy policies for a
specific site were compared to overall specific policies that the firm could include in a
policy, but may have chosen not to include. This study only analyzed which personal data
the site indicated that it captured, and did not investigate the firm’s storage,
dissemination, protection, or destruction of the consumer data.
Overall privacy policy
A site can contain an overall privacy policy page that could be accessed in a
variety places throughout the Web site. Ideally, a privacy page link should be found at the
bottom of the index (or home) page of the site for ease of access. Links to the privacy
page could be found on other non-home pages but may present difficulties in consumers
finding the page. This study determined if an online pharmacy site contained a privacy
policy page, and where on the site it could be accessed.
Privacy seal use
Online pharmacy sites can use independent third-party organizations such as
TRUSTe and BBBOnLine in order to enhance consumer confidence in overall operations
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as well as their privacy policy. In order to use the reliability seal of approval, an e-
business must adhere to established privacy principles promulgated by these third-party
organizations. Sites that hold sway to the principles of these seal programs may have the
privacy seal icons on their site, and the research analyzes if pharmacy sites use either of
these seals. Online sites often place these privacy seals on the home page, but it is
conceivable they may be found on other pages. The study determines if two of the most
common privacy seals (TRUSTe and BBBOnLine) were found within the sites.
Demographic information
Sites can collect a variety of information about their customers, some of which
may be required by the pharmacy and other data that the user optionally chose to divulge.
This research analyzed whether the privacy policy revealed if the site collected the
following demographic information: email, address, social security number, telephone,
credit card, and demographics (age and gender).
Medical information
Sites can collect a variety of information about their customers, some of which
may contain highly personal and confidential data. The study reviewed whether the site’s
privacy policy indicated whether medical information was collected and kept
confidential.
Use of cookies
Cookies are small text files, placed on a user’s computer by the site’s server
programs. Sites use cookies for a variety of reasons, such as saving login information
(such as user ID and password) to provide for quicker logins. Previous login session
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information may be saved in cookies for use in subsequent sessions. For example, an
online pharmacy site could place a cookie on a consumer’s computer the first time the
customer signs into the site to purchase a prescription. When a consumer subsequently
desires to purchase pharmaceuticals and signs into the site, the cookie could contain the
user’s ID and password for faster login. If a site uses cookies, the usage policy may be
included in the privacy page so users understand the reasons for their use, and how
cookies may benefit them. This study examined if a site disclosed its cookie policy on the
site.
Computer hardware and software information collect from cookies
Firms collect a variety of information about users and store this data in cookie
files. Surfing patterns can be used to help keep track of popular and rarely used pages,
thus providing the site operator with data useful in making beneficial changes to these
pages. This study assessed the following hardware and software information that sites
collected: Internet Protocol (IP) address, browser types, referring Web site address, log
files, usage tracking, and domain name.
Opt-in and opt-out
Online marketers have two tactics for permission marketing: opt-in and opt-out.
Opt-in refers to a consumer taking voluntary action to receive something; it is initiated by
a consumer. Opt-out refers to the ability to decline further services, such as email. In opt-
out, a consumer may have voluntarily signed up for a service, and then later decides not
to use the service, thus “opting-out.” In addition, online vendors may acquire email
listings and send spam to consumers. If consumers no longer wish to receive the notices,
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they must follow the opt-out procedures. It should be noted that Canadian law requires an
opt-in while the U.S. approach is opt-out. (Canada Privacy Commissioner, 2003b, para.
4) Each option was analyzed in this study.
Personal update of information in system
Because of changing consumer medical and personal data, it is critical for these
sites to provide their consumers with the ability to update and delete personal
information, especially medical records that can have an effect on health. Three update
options were analyzed. First, the study determined if the privacy policy stated that
consumers could delete information from the site. Next, the site was analyzed to ascertain
if the privacy policy reveals whether users can delete archived information. Finally, the
research ascertained if a consumer could update information in the site’s database.
Disclosure of information to third parties and affiliates
A privacy page may contain disclosure information that indicates if the hosting
site reveals personal information to third party entities or affiliates. This dissertation
began by determining if the site indicated whether it disclosed data to third parties and if
the customer had the ability to consent to this action. Next, statistics were gathered
indicating whether the site disclosed data if required to perform services, if legally
required, if the firm is acquired by another, or if the site shared information with
affiliates.
Steps firms take to provide security
The safety of personal information is one concern of consumers when reviewing a
site’s privacy policy page. A common online security method is to provide login IDs and
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passwords to users’ account profile screen. Passwords are the initial barrier to prevent
unauthorized access to personal information. Firewalls, SSL, and encryption techniques
are other ways to secure data. At the firm’s physical location, servers can be stored in a
protected environment. In addition, only authorized company employees should have
access to the data. This study evaluated the site’s policy page to determine what security
processes and methods were utilized.
Absolving data collection
When consumers post their medical and personal information to a pharmacy site,
that information will be used by that specific online firm. However, it is conceivable that
unethical firms or individuals could collect information and use it for dubious means.
Thus, it is imperative that online sites disclaim any intention of inappropriate use of a
consumer’s data by third parties. An analysis of the policies revealed if the site rejected
third-party data collection.
Collection of data from children under 13
The U.S. Children’s Online Privacy Protection Act (COPPA) was designed to
thwart the collection of personally identifiable information from children without their
parents’ consent. Although it is highly unlikely that any child would need to use the
services of an online pharmacy site, it would still be advantageous to indicate that the site
complies with U.S. law because of the number of U.S. consumers who use the site.
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Will post changes to privacy policy
As business requirements and laws change, a company should periodically review
its privacy policy. If the firm modifies its policies, updates should be posted to the
privacy page, thus keeping consumers up-to-date with guidelines.
Provides email or phone contact on privacy page
Online consumers may pose questions about the firm’s privacy policies and
statement, and may desire clarification. Therefore, contact information should be
provided on the privacy policy page, such as a firm’s phone number or contact email
address. The research verified if sites used contact information on their privacy page.
Licensing
This research study analyzed whether the site contained licensing information
about the pharmacy. An online pharmacy site could exist under one of three possible
scenarios. First, it may not be licensed in either Canada or the U.S. Second, the Web
pages may actually show a valid American or Canadian pharmacy license on the Web
site. Third, the firm may function as a pharmacy intermediary, and have a third-party
pharmacy fill its orders.
Research Approval
The project approval for the online consumer survey portion of this project was
submitted to the Nova Southeastern University Institutional Review Board (IRB) for
examination and approval. The project was accepted on December 20, 2004, and the IRB
approval can be found in Appendix E.
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Reliability and Validity
In order to assure the reliability of the online survey questions and to ensure that
survey respondents correctly understood the process, the researcher conducted a short test
of the survey questions with a pre-selected class of undergraduate students at St.
Petersburg College. Allowing students to take the survey before the intended audience
helped to establish that the questionnaire and the methodology were appropriate for this
study. The students were asked to take the online survey of questions and were evaluated
as a group as to the validity of the survey. Students were able to complete the questions
within a 10-15 minute estimated time frame. The students were asked if they required
clarification of any question, and if they understood the context of each of the questions.
There were no issues associated with the survey.
After validation by a small sample of 10 students, the survey was made available
to the consumers of the medical Web sites. In order not to annoy consumers with a
lengthy questionnaire and to increase the likelihood that all questions were completed, it
was decided to keep the survey to 44 questions that could be completed in 10-15 minutes.
Because all the pretest respondents were able to complete the survey within this time, this
should have validated that the larger group to be surveyed should also have been able to
answer the questions within a similar time frame.
Assumptions
The medical Web sites chosen for the second portion of this study were assumed
to contain a cross-section of consumers who were interested in medical issues, such as
pharmaceutical concerns. The researcher presumed a certain portion of these medical site
users used Canadian online pharmacies for their drug purchases, while the others used
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more traditional channels of pharmaceutical distribution. It was further assumed that a
random sampling of interested users would choose to take the survey. However, no
controls were placed on these respondents to determine if their responses would be
accurate. It is conceivable that some of the respondents could have been predisposed
towards a certain bias, and may have answered questions based on their perceptions, not
necessarily on their experiences. The possibility may also exist that strong user beliefs
about privacy issues or beliefs in the issues of perceived high prices of drugs may have
led users to skew the responses to questions in a certain direction.
Summary
This chapter summarized the research methodology that was used for two phases
of this project: an online site evaluation and a user survey. The specific instrumentation
was detailed as well as the specific procedures employed. Finally, the assumptions and
limitations were reviewed in order to serve as an introduction to the results discussed in
the next chapter.
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Chapter 4
Results
Introduction
This chapter reviews the findings of an in-depth analysis of the privacy policies
and procedures of 25 major online Canadian pharmacies, as well as the purchasing
patterns and viewpoints of 147 consumers. The results provide information on consumer
demographics, and the Web sites' overall privacy policy, consumer/licensing, collection
of personal demographic information, use of cookies, opt-in/opt-out/update ability, third
party disclosure, security, and miscellaneous characteristics.
Consumer Survey Analysis
Available through four Web sites (DrKoop.com, HealthCentral.com,
MDchoice.com, and HealthScout.com), the online consumer survey collected data about
the purchasing patterns and viewpoints of 147 consumers. The data were collected over a
two-month time-frame. If respondents clicked the text link to enter the survey but did not
actually start or complete the survey, the resulting data were not included in the results.
The responses were collected via a survey hosting company, and the data were
incorporated into an Excel file for analysis.
Consumer Survey Findings
Consumer Demographics
Nearly half of the respondents (n=66, 44.6%) were under 40 years of age, while
60 (40.5%) were age 41-60, and 21 (14.2%) were over age 60. There was an almost equal
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division in gender (female: n=70, 47.3%; male: n=78, 52.7%). According to December
(2005), a 2001 Pew study determined that the gender gap in Internet access has narrowed;
for example, of the 104 million American adults with Internet access, just over half
(50.6%) are women. As with the demographic question on age, the results of this survey
do have a correlation with the average Internet user. Most participants (n=103, 69.6%)
had an insurance plan. Of the 147 individuals surveyed, only 14 (9.5%) used an online
Canadian pharmacy. Currently, only 4% of all U.S. consumers have purchased
prescription drugs online (Resnick & Montania, 2003). This fits into the pattern of a low
percentage of respondents indicating they had used online pharmacies.
Online Purchasing Factor Findings
Tables 1 through 10 show the frequency of respondents’ answers to specific
questions. For example, the left column on Table 1 shows whether the respondents have
used an online pharmacy (“yes” response in left column) or have not used this type of
pharmacy (“no” response in left column). The three columns to the right-hand side shows
what the respondents answered (“yes” or “no”) to the specific survey question. The “yes”
column on the right-hand side of the table indicates a specific factor was important to the
respondents, while a “no” response designates the factor was not important. For example,
in Table 1, under the vertical “yes” column, 10 respondents who had actually used an
online pharmacy viewed cost as an important factor in their online purchase.
Table 1 shows that 14 (9.5%) respondents answered portions of question series
number 5 in Appendix C, indicating that they had purchased pharmaceuticals from an
online Canadian pharmacy within the previous 12 months, while 133 respondents did not
answer the series of question in this section. Ten (71.4%) of the 14 online buyers
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answered question 5a (shown as “q5a” in Table 1 and “qxa” in subsequent tables in this
section) and stated they considered the cost of pharmaceuticals available online before
deciding whether to submit an online order. An interesting point was that although non-
purchasers of pharmaceutical sites were not supposed to answer the question related to
cost savings (question 5a in Appendix C), four respondents (3.0%) did respond that they
would consider cost savings if they would eventually purchase from these sites.
Table 1. Frequency of Considering Cost for Online Purchases
Cost
Online Yes No Total
Count 10 4 14
% within online 71.4% 28.6% 100.0%
% within q5a (cost) 71.4% 3.0% 9.5%
Yes
% of total 6.8% 2.7% 9.5%
Count 4 129 133
% within online 3.0% 97.0% 100.0%
% within q5a (cost) 28.6% 97.0% 90.5%
No
% of total 2.7% 87.8% 90.5%
Count 14 133 147Total
% of total 9.5% 90.5% 100.0%
Table 2 illustrates the importance consumers view privacy policies on a site when
they have purchased from an online pharmacy. This relates to question 5b within
Appendix C. Fourteen (9.5%) of the147 respondents reported on question 5c that they
had purchased online pharmaceuticals, and three (21.4%) online buyers, and 2.0% of total
respondents stated that they considered the presence of a stated privacy policy to be an
important factor before deciding whether to purchase from the firm.
Table 3 indicates whether convenience of placing orders was deemed important
to online pharmacy consumers. Eight (57.1%) online buyers of question 5c, (5.4% of
total respondents) considered convenience an important factor when placing an online
order for Canadian pharmaceuticals.
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Table 2. Frequency of Considering Privacy Policy for Online
Purchases
Privacy Policy
Online Yes No Total
Count 3 11 14
% within online 21.4% 78.6% 100.0%
% within q5b (privacy) 100.0% 7.6% 9.5%
Yes
% of total 2.0% 7.5 9.5
Count 0 133 133
% within online 0.0% 100.0% 100.0%
% within q5b (privacy) 0.0% 92.4% 90.5%
No
% of total 0.0% 90.5% 90.5%
Count 3 144 147Total
% of total 2.0% 98.0% 100.0%
Table 3. Frequency of Considering Convenience for Online
Purchases
Convenience
Online Yes No Total
Count 8 6 14
% within online 57.1% 42.9% 100.0%
% within q5c
(convenience)
100.0% 4.3% 9.5%
Yes
% of total 5.4% 4.1% 9.5%
Count 0 133 133
% within online 0.0% 100.0% 100.0%
% within q5c
(convenience )
0.0% 95.7% 90.5%
No
% of total 0.0% 90.5% 90.5%
Count 8 139 147Total
% of total 5.4% 94.6% 100.0%
Table 4 shows 14 (9.5%) of the 147 respondents reported on question 5e
regarding the importance of availability when deciding to purchase. Three (21.4%) of the
online buyers (2.0% of all respondents) considered drug availability an important issue.
Consumers taking the survey may have found “other” reasons for considering
whether to purchase from a Canadian online pharmacy (shown in Table 5). A majority of
those who made an online purchase within the past year (n=10, 71.4%) considered other
issues. This was 6.8% of the total respondents.
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Table 4. Frequency of Considering Availability for Online
Purchases
Availability
Online Yes No Total
Count 3 11 14
% within online 21.4% 78.6% 100.0%
% within q5d
(availability)
100.0% 7.6% 9.5%
Yes
% of total 2.0% 7.5 9.5
Count 0 133 133
% within online 0.0% 100.0% 100.0%
% within q5d
(availability)
0.0% 92.4% 90.5%
No
% of total 0.0% 90.5% 90.5%
Count 3 144 147Total
% of total 2.0% 98.0% 100.0%
Table 5. Frequency of Considering Other Reasons for Online
Purchases
Other
Online Yes No Total
Count 10 4 14
% within online 71.4% 28.6% 100.0%
% within q5e (other) 100.0% 2.9% 9.5%
Yes
% of total 6.8% 2.7% 9.5%
Count 0 133 133
% within online 0.0% 100.0% 100.0%
% within q5e (other) 0.0% 95.7% 90.5%
No
% of total 0.0% 90.5% 90.5%
Count 10 137 147Total
% of total 6.8% 93.2% 100.0%
Table 6 outlines the findings for respondents’ views on legal issues raised when
using a Canadian online pharmacy. Of the 133 total respondents who did not use a
Canadian pharmacy, a majority of respondents (n=68, 51.1%) revealed legal concerns
kept them from making online pharmacy purchases. One respondent who made a
pharmacy purchase within the past 12 months also answered this question expressing a
concern about legal problems.
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Table 6. Frequency of Considering Legal Issues for Online
Purchases
Legal
Online Yes No Total
Count 1 13 14
% within online 7.1% 92.9% 100.0%
% within q6a (legal) 1.4% 16.7% 9.5%
Yes
% of total 0.7% 8.8% 9.5%
Count 68 65 133
% within online 51.1% 48.9% 100.0%
% within q6a (legal) 98.6% 83.3% 90.5%
No
% of total 46.3% 44.2% 90.5%
Count 69 78 147Total
% of total 46.9% 53.1% 100.0%
The findings in Table 7 indicate whether lack of trust of online commerce was a
factor that inhibited survey respondents from making an online pharmacy purchase. Few
of the respondents (n=19, 14.3%) who did not make an online purchase found trust to be
an overriding factor.
Table 7. Frequency of Considering Trust for Online Purchases
Trust
Online Yes No Total
Count 0 14 14
% within online 0.0% 100.0% 100.0%
% within q6b (trust) 0.0% 10.9% 9.5%
Yes
% of total 0.0% 9.5 % 9.5%
Count 19 114 133
% within online 14.3% 85.7% 100.0%
% within q6b (trust) 100.0% 89.1% 90.5%
No
% of total 12.9% 77.6% 90.5%
Count 19 128 147Total
% of total 12.9% 77.6% 100.0%
Table 8 indicates the importance consumers place on the privacy of their personal
medical data on a site, and whether their concerns prevented them from making online
pharmacy purchases. Approximately one-third (37.6%) of 133 respondents reported on
question 6c that they considered privacy issues a reason for not shopping online.
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Table 8. Frequency of Considering Privacy for Online Purchases
Privacy
Online Yes No Total
Count 0 14 14
% within online 0.0% 100.0% 100.0%
% within q6c
(privacy)
0.0% 14.4% 9.5%
Yes
% of total 0.0% 9.5 % 9.5%
Count 50 83 133
% within online 37.6% 62.4% 100.0%
% within q6c
(privacy)
100.0% 85.6% 90.5%
No
% of total 34.0% 56.5% 90.5%
Count 50 97 147Total
% of total 34.0% 56.5% 100.0%
Table 9. Frequency of Considering Quality for Online Purchases
Quality
Online Yes No Total
Count 0 14 14
% within online 0.0% 100.0% 100.0%
% within q6d (quality) 0.0% 13.2% 9.5%
Yes
% of total 0.0% 9.5 % 9.5%
Count 41 92 133
% within online 30.8% 69.2% 100.0%
% within q6d (quality) 100.0% 86.8% 90.5%
No
% of total 27.9% 62.6% 90.5%
Count 41 106 147Total
% of total 27.9% 62.6% 100.0%
Table 9 outlines the findings for respondents’ views on the quality of drugs when
deciding to use online Canadian pharmacies. Approximately one-third (n=41, 30.8%) of
survey respondents to this question held the view that the inability to guarantee the
quality of drugs adversely affected their desire to complete online purchases from
Canadian pharmacy Web sites.
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Table 10. Frequency of Considering Other Factors for Online Purchases
Other
Online Yes No Total
Count 3 11 14
% within online 21.4% 78.6% 100.0%
% within q6e (other) 2.8% 28.2% 9.5%
Yes
% of total 2.0% 7.5 % 9.5%
Count 105 28 133
% within online 78.9% 21.1% 100.0%
% within q6e (other) 97.2% 71.8% 90.5%
No
% of total 71.4% 19.0% 90.5%
Count 108 39 147Total
% of total 73.5% 26.5% 100.0%
Consumers taking the survey may have found “other” reasons for not purchasing
from a Canadian online pharmacy. Table 10 shows if “other” factors were an issue to
consumers. A majority of those who did not make online purchases within the past year
(n=105, 78.9%) consider other issues. In addition, three respondents (n= 21.4%) of the 14
consumers who did make an online purchase also answered this question.
For survey respondents using a pharmacy "cost saving" (10 respondents within
Table 1) and “none of the above” (10 respondents within Table 5) were the two main
reasons given for making online purchases. For those consumers who had not used an
online Canadian pharmacy in the past year, "legal issues" (68 respondents within Table 6)
and “none of the above” (105 respondents within Table 10) were the most frequently
noted explanations.
Consumer Purchasing Patterns and Viewpoints
This section provides a detailed analysis of consumer responses for each of the
eight categories of information. Table 11 summarizes respondents’ views about the
presence of privacy policies on the Canadian pharmacy Web sites listed in Appendix A,
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as well as a site’s use of privacy seal programs, such as BBBOnLine. Most respondents
(n=84, 56.8%) agreed (summation of the “disagree” and “strongly disagree” cells for this
and subsequent calculations in this section) that an online pharmacy should provide a link
to their privacy policy on their home page. Likewise, 66.2% (n=98) of the participants
responded negatively to Web sites whose privacy policies were not available via their
home pages or that did not make their privacy policies available (n = 96, 64.9%). In
addition, half of the respondents believe that a privacy seal program increased their trust
in the Web site, while only 22.3% (n=23) disagreed. This last point was verified by
Pennington, who indicates that privacy seals enhance trust in Internet sites (Pennington et
al., 2003).
Table 11. Consumer Survey - Overall Privacy Findings
Strongly
Agree Agree Neither Disagree
Strongly
Disagree NA
Site Characteristic n % n % n % n % n % n %
Link on home page 25 16.9 59 39.9 44 29.7 18 12.2 0 0 1 0.6
No link on home
Page 1 0.6 1 0.6 45 30.4 74 50.0 24 16.2 1 0.6
No posted policy 0 0.0 4 2.7 45 30.4 74 50.0 22 14.9 1 0.6
Use Seal 29 16.9 45 30.4 37 25.0 27 18.2 6 4.1 3 2.0
Table 12 shows the statistical findings on consumers’ views regarding licensing
and collection of prescription and health information. Respondents placed a high value on
a pharmacy possessing a valid license (n=111,75%,), as well as being an actual pharmacy
rather than a pharmacy intermediary (n=81, 54.8%,).
Pharmacy requirements for a consumer health profile and actual prescription
script were slightly lower in consumer desirability. Most consumers either disagreed
(n=48, 32.5%) with or felt neutral (n=50, 33.8%) about having to complete a required
health profile. This may be due to the concerns of consumers when firms keep sensitive
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data, such as health information. This was discussed by Choy et al. who indicates that
trepidation about privacy makes online disclosure of medical information an especially
sensitive issue to online consumers (Choy et al., 2001). This was also validated in the
results of Table 8, showing that consumers placed a high priority in the privacy of their
medical data, and would consider lack of privacy a reason for not shopping online.
Similarly, the majority of respondents either felt either neutral (n=42, 28.4%) or
disagreed (n=50, 33.8%) with the requirement to provide an actual prescription for their
prescription. However, over one-third (n=55, 37.2%) agreed with the prescription
requirement, thus indicating a large deviation among consumer views on this issue.
Table 12. Consumer Survey - Licensing Findings
Strongly
Agree Agree Neither Disagree
Strongly
Disagree NA
Site Characteristic n % n % n % n % n % n %
License 38 25.7 73 49.3 30 20.2 6 4.1 0 0.0 1 0.6
Actual Pharmacy 30 20.3 51 34.5 51 34.5 15 10.1 0 0 1 0.6
Health profile 17 11.5 32 21.6 50 33.8 46 31.1 2 1.4 1 0.6
Prescription 17 11.5 38 25.7 42 28.4 43 29.1 7 4.7 0 0.0
Table 13 displays consumers’ views related to collecting personal demographic
information. Respondents indicated strong negative reactions across each of the five
categories towards a site collecting personal information. More specifically, they
disagreed with data collection of email addresses (n=78, 52.7%), mailing addresses
(n=79, 53.4%), telephone numbers (n=80, 54%), credit card information (n= 86, 58.1%),
and age and gender (n=66, 44.6%).
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Table 13. Consumer Survey - Personal Demographic Findings
Strongly
Agree Agree Neither Disagree
Strongly
Disagree NA
Site Characteristic n % n % n % n % n % n %
Email 2 1.4 19 12.8 46 31.1 61 41.2 17 11.5 1 0.6
Mail address 2 1.4 20 13.5 44 31.1 59 39.9 20 13.5 1 0.6
Telephone 2 1.4 20 13.5 43 29.1 61 41.2 19 12.8 1 0.6
Credit card 2 1.4 16 10.8 41 27.7 55 37.2 31 20.9 1 0.6
Demographic 3 2.0 15 10.1 61 41.2 45 30.4 21 14.2 1 0.6
Computer hardware, software and cookie tracking results are compiled in Table
14. The findings illustrate consumers' strong propensity to disagree with the use of
cookies and other software and hardware tracking. A small minority of respondents
(n=16, 10.8%) agreed with cookie usage, while most disagreed with cookie tracking
(n=79, 53.3%) and computer tracking (n=81, 54.8%). However, there were also a sizable
number of respondents who were neutral towards using cookies (n=49, 33.1%) and usage
tracking (n=49, 33.1%).
Table 14. Consumer Survey - Hardware/Software and Cookie Findings
Strongly
Agree Agree Neither Disagree
Strongly
Disagree NA
Site Characteristic n % n % n % n % N % n %
Uses cookies 3 2.0 13 8.8 49 33.1 60 40.5 19 12.8 2 1.4
IP address 3 2.0 12 8.1 50 33.8 57 38.5 23 15.5 1 0.6
Usage track 3 2.0 12 8.1 49 33.1 55 37.2 26 17.6 1 0.6
Domain name 3 2.0 13 8.8 47 31.8 58 39.2 24 16.2 2 1.4
The ability to modify or delete consumer information, along with opt-in and opt-
out capability, showed to be desirable for most respondents (Table 15). Over half (n=88,
59.4%) of the respondents agreed that the ability to opt-out was a positive characteristic,
as well as the opt-in characteristic (n=91, 61.4%). These results are validated by outside
researchers, such as Adkinson et al. (2002) who indicated that Web users show a marked
preference for opt-in policies. A similar number of respondents found it important to be
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able to delete consumer information (n=88, 59.5%) as well as amend their personal data
(n=87, 58.8%).
Table 15. Consumer Survey - Opt-In and Alteration Findings
Strongly
Agree Agree Neither Disagree
Strongly
Disagree NA
Site Characteristic n % n % n % n % n % n %
Can delete 26 17.6 62 41.9 53 35.8 6 4.1 0 0.0 1 0.6
Can alter 26 17.6 61 41.2 50 33.7 7 4.7 1 0.6 1 0.6
Opt-out 31 20.9 57 38.5 50 33.7 6 4.1 0 0.0 2 1.4
Opt-in 31 20.9 60 40.5 48 32.4 4 2.7 1 0.6 2 1.4
Table 16 outlines the findings for respondents’ views on information disclosure to
third parties and affiliate firms. A positive view was held of pharmacies that do not
disclose consumer information, with 75.7% (n=112) of respondents agreeing that not
disclosing information is indicative of a pharmacy’s trustworthiness. Likewise,
respondents revealed negative opinions (85.1%, n=126) about pharmacies that disclose
consumer information to third-party firms, while 79.7% (n=118) disagreed with
disclosing information to affiliates.
A smaller percentage of respondents expressed strong views towards pharmacies
that disclose information when legally required, or if the consumers gave prior consent
for disclosure. For pharmacies that must legally disclose information, the majority of
respondents (n=70, 47.3%) held a neutral view. Over 40% (n=60) of respondents had a
neutral view regarding consumer disclosure upon consent to release information, while
30.4% (n=53) agreed the practice is acceptable.
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Table 16. Consumer Survey - Disclosure Findings
Strongly
Agree Agree Neither Disagree
Strongly
Disagree NA
Site Characteristic n % n % n % n % n % n %
Does not disclose 51 34.5 61 41.2 41 20.9 2 1.4 1 0.6 0 0.0
Does disclose 1 0.6 0 0.0 18 12.2 65 43.9 61 41.2 1 0.6
Consent to release 8 5.4 45 30.4 60 40.5 29 19.6 3 2.0 1 0.6
Perform services 2 1.4 13 8.8 58 39.2 57 38.5 14 9.5 0 0.0
Legally required 4 2.7 25 16.9 70 47.3 41 27.7 5 3.8 1 0.6
Acquired 1 0.6 2 1.4 61 41.2 66 44.6 15 10.1 1 0.6
Affiliates 1 0.6 0 0.0 26 17.6 66 44.6 52 35.1 1 0.6
Absolve URL 1 0.6 2 1.4 23 15.5 64 43.2 52 35.1 1 0.6
Third parties 1 0.6 0 0.0 21 14.2 62 41.9 59 39.9 2 1.4
Table 17. Consumer Survey - Security Findings
Strongly
Agree Agree Neither Disagree
Strongly
Disagree NA
Site Characteristic n % n % n % n % n % n %
SSL 26 17.6 58 39.2 45 30.4 14 9.5 1 0.6 2 1.4
Employees 29 19.6 56 37.8 41 27.7 14 9.5 2 1.4 2 1.4
Password 32 21.6 51 37.8 40 27.0 16 10.8 1 0.6 2 1.4
Firewall 27 18.2 55 37.2 42 28.4 15 10.1 1 0.6 2 1.4
Physical protection 32 21.6 53 35.8 40 27.0 14 9.5 1 0.6 2 1.4
The data in Table 17 show that respondents placed a high value on privacy
policies that feature security characteristics. Over half (n=84, 56.8%) found favor with
pharmacies whose privacy policy stated they offer Secure Sockets Layer (SSL) security
on their Web site. The majority of respondents (n=85, 57.4%) also favored pharmacies
who restricted their employees' access to confidential information, while 56.1% (n=83)
approved of password protection, 55.4% (n=82) with firewall protection, and 57.4%
(n=85) endorsed the practice of maintaining data in a secure environment. Interestingly, a
few respondents disagreed with pharmacies posting information about their security
characteristics in their privacy policies. The number of negative respondents ranged from
a low of 15 respondents (10.1%) for physical protection to a high of 17 respondents
(11.4%) for password protection.
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Table 18. Consumer Survey - Miscellaneous Information Findings
Strongly
Agree Agree Neither Disagree
Strongly
Disagree NA
Site Characteristic n % N % n % n % n % n %
COPPA 12 8.1 18 12.2 56 37.8 47 31.8 4 2.7 3 2.0
Post changes 12 8.1 20 13.5 61 41.2 43 29.1 3 2.0 1 0.6
Email / phone 13 8.8 45 30.4 44 29.7 36 24.3 1 0.6 0 0.6
Table 18 illustrates the findings for several miscellaneous privacy policy
characteristics. First, most respondents either had a neutral view (n=56, 37.8%) or
disagreed (n=47, 31.8%) that posting a COPPA policy is advantageous. Only 21.6%
(n=32) of respondents were in favor of a pharmacy stating that changes are posted to their
privacy policy. A wide divergence of views existed on whether a pharmacy should post
an email or telephone contact on their privacy policy page. Specifically, over one-third
(39.2%) of respondents agreed, 29.7% were neutral, and 24.9% disagreed.
Pharmacy Web Site Analysis and Findings
The number of Canadian pharmacies that display privacy policies within their
Web sites is illustrated in Table 19. The majority of sites placed the link on their home
page (n=16, 64.0%), while 22% (n=3) placed a privacy link elsewhere on their site. Three
sites did not contain a privacy policy link. One consequence of this practice is to create a
hardship for site users, who may overlook a privacy policy where the link is not posted
on the home page. Because the majority of sites do post privacy policies on their pages,
this could result in a positive impact to online consumers’ views of the sites. As indicated
in Table 11, most survey respondents maintained that online pharmacies should provide
privacy policy links on their home page, and responded negatively to sites that did not
post policies.
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Table 19. Pharmacy Review - Overall Privacy Findings
Yes No
Site Characteristics n % n %
Privacy link on home page 16 64.0 9 36.0
Privacy link on non-home page 3 22.0 22 88.0
No privacy policy 3 22.0 22 88.0
Table 20 shows seven pharmacies (28%) indicated membership with the Canadian
International Pharmacy Association (CIPA). None indicated participation in the Verified
Internet Pharmacy Practice Sites (VIPPS), a division of the National Association of
Boards of Pharmacy. Marketing research studies by Pennington et al. (2003) reveal that
displaying privacy seals, such a BBBOnLine or TRUSTe, has a positive impact on
consumers’ views of online sites. This view corresponds to the results in this study shown
in Table 11, where most respondents felt that a privacy seal program was beneficial.
However, despite these research findings, most of the 25 online pharmacies surveyed did
not use this valuable tool.
Table 20. Pharmacy Review - Privacy Seal Findings
Yes No
Site Characteristics n % n %
BBBonline 3 12.0 22 88.0
TRUSTe 1 4.0 24 96.0
CIPA 7 28.0 18 72.0
VIPPS 0 0.0 25 100.0
The results of Table 12 show a large number of respondents are concerned about
the online pharmacy holding a valid pharmacy license. Seventy-five percent of
consumers felt that a licensed pharmacy was valuable, and 54% felt it was important to
be an actual pharmacy instead of an intermediary. Contrary to consumers’ desires, not all
pharmacies are licensed, or if they are, they may not specify this designation on their site.
In a study of Canadian online pharmacies, PharmacyChecker.com (2003b) estimated that
50% of sites do not hold valid Canadian pharmacy licenses. Table 21 illustrates that 68%
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(n=17) of pharmacies in this study display ownership of a license on their Web site.
Forty-four percent of the Web sites (n=11) indicated they are actual pharmacies as
opposed to intermediaries.
Table 21. Pharmacy Review - Licensing Findings
Yes No
Site Characteristics n % n %
License number on site 17 68.0 8 32.0
Actual pharmacy 11 44.0 14 56.0
Prescription through affiliate 14 56.0 18 44.0
As can be seen in Table 22, 96% (n=24) of the pharmacies in this study indicated
in their privacy policies that they require a completed health profile and an original
prescription (or copy) in order to purchase prescriptions on their Web site.
Table 22. Pharmacy Review - Medical Information Findings
Yes No
Site Characteristics n % n %
Health profile 24 96.0 1 4.0
Requires prescription 24 96.0 1 4.0
Table 23 exhibits the pharmacies whose privacy policies designate the specific
types of personal and demographic information they collect. Approximately one-third of
pharmacies (28% - 36%) revealed they collect some information, such as the customer's
email, address, telephone number, credit card information, and demographics (i.e., age,
gender). The pharmacies did not show a propensity to request consumers' social security
numbers. Web site collection of personal data on Canadian pharmacies contradicts
consumers views compiled in Table 13. Survey takers had negative reactions to firms
collecting personal data, yet privacy policies results in Table 23 show firms continue to
collect this information.
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Table 23. Pharmacy Review - Demographic Information Findings
Yes No
Site Characteristics n % n %
Email 8 32.0 17 68.0
Social security 0 0.0 25 100.0
Address 9 36.0 16 64.0
Telephone 9 36.0 16 64.0
Credit card 9 36.0 16 64.0
Demographics 7 28.0 18 72.0
Table 24 illustrates that few of the Canadian online pharmacies (n=8, 32.0%)
explicitly mention that they use cookies. Nine of the privacy policies reviewed in this
study indicated the use of third-party cookies. Consumer attitudes found in Table 14
show that most respondents (n=79, 52.8%) disagreed with cookie tracking, so the
collection results showing minimal cookie usage in Table 24 may indicate consumers
would view these online Canadian pharmacies in a more positive light.
Table 24. Pharmacy Review - Cookies Findings
Yes No
Site Characteristics n % n %
Use cookies 8 32.0 17 68.0
Third party cookies 9 36.0 16 64
Table 25 shows that few online pharmacies in this research study posted
statements revealing they collect information through tracking. Six pharmacies (24.0%)
mentioned that they collect IP addresses and use consumer hardware information to track
consumer usage patterns. Only 8.0% (n=2) confirmed they collect information on
browser types and domain names, while 4.0% (n=1) admit to collecting data on referring
Web site addresses and log files.
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Table 25. Pharmacy Review - Hardware/Software Tracking Findings
Yes No
Site Characteristics n % n %
IP address 6 24.0 19 76.0
Browser types 2 8.0 23 92.0
Refer Web site address 1 4.0 24 96.0
Log file 1 4.0 24 96.0
Usage tracking 6 24.0 19 76.0
Domain name 2 8.0 23 92.0
An interesting result, shown in Table 26, is that few online pharmacies mention
their opt-in or opt-out policies. None showed that they subscribe to opt-in guidelines and
21 (84.0%) mentioned opt-out options. This result validates Cadogan’s (2001) research
that explains most online merchants prefer to use opt-out strategies as opposed to opt-in.
Table 26. Pharmacy Review - Opt-in / Opt-out Findings
Yes No
Site Characteristics n % n %
Opt-in 0 0.0 25 100.0
Opt-out 21 84.0 4 16.0
Table 27. Pharmacy Review - Ability to Update Data Findings
Yes No
Site Characteristics n % n %
Delete information 2 8.0 23 92.0
Delete from archive 0 0.0 25 100.0
Update/amend data 10 40.0 15 60.0
Few pharmacy Web sites denote that they allow customers to delete information
from their databases (n=2, 8.0%) or their archived backup databases (n=0, 0%). A higher
percentage of Web sites (n=10, 40.0%) display policies that inform consumers they can
update or amend their personal information (Table 27). Yet, consumer preference in
Table 15 indicates that the ability to delete or alter information is important to consumers,
with 59.5% relating it is important to be able to delete information and 58.8% finding it
important to amend personal data.
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Table 28. Pharmacy Review - Disclosure Findings
Yes No
Site Characteristics n % n %
Does not share with third party 12 48.0 13 52.0
Discloses data to third party 2 8.0 23 92.0
Discloses if consent 6 24.0 19 76.0
Discloses if performing services 7 28.0 18 72.0
Legally required 11 44.0 14 56.0
Merger 8 32.0 17 68.0
Disclose to affiliates 6 24.0 19 76.0
Table 28 shows that approximately half (n=12, 48.0%) of the pharmacies
surveyed in this study have privacy policies that specify they do not share information
with third parties. Only 8.0% (n=2) post that they disclose information to third-party
firms, 24.0% (n=6) disclose information if the consumer consents, 28.0% (n=7) disclose
data if performing services, 44.0% (n=11) if legally required, 32.0% (n=8) if the firm
merges, and 24.0% (n=6) denote they release data to affiliates.
Table 29. Pharmacy Review - Security Findings
Yes No
Site Characteristics n % n %
SSL 6 24.0 19 76.0
Restrict employee access 5 20.0 20 80.0
Passwords 3 12.0 22 88.0
Third-party credit card process 0 0.0 25 100.0
Firewalls 3 12.0 22 88.0
Physical protection 5 20.0 20 80.0
Security issues compiled in Table 17 show respondents place a high value on
information security. Yet, the statistics of online firms who post comprehensive security
policies on their privacy site does not correspond to consumers’ desires. Table 29 shows
that a minority of the pharmacies display information about the security characteristics of
their Web sites. Findings range from a high number (24.0%, n=6) of pharmacies who
post information about their use of SSL security to a low number (0.0%, n=0) of
pharmacies who reveal their use of third-parties to process credit card data.
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Table 30. Pharmacy Review - Absolve Collection Findings
Yes No
Site Characteristics n % n %
Absolves outside links 3 12.0 22 88.0
Absolves data collection 4 16.0 21 84.0
The findings in Table 30 indicate whether or not online pharmacies exempt
themselves from legal issues resulting from third-parties collecting data from their Web
sites. Few of the pharmacies discharge liability third-party firms or links from third-party
Web sites. Only 12.0% (n=3) of pharmacies absolve themselves when outside online
firms link to their Web site, and 16.0% (n=4) release themselves from issues related to
data collected by third parties.
A variety of miscellaneous findings are reviewed in Table 31. None of the online
pharmacies surveyed post information about the legal requirements of the Children's
Online Privacy Protection Act (COPPA). Over half of the pharmacies (n=13, 52%) have
posted an email or phone contact on their privacy policy page, and 40.0% (n=10) state
that they post updates to the privacy policy when changes occur.
Table 31. Pharmacy Review - Miscellaneous Findings
Yes No
Site Characteristics n % n %
COPPA 0 0.0 25 100.0
Changes to policy 10 40.0 15 60.0
Email or phone contact 13 52.0 12 48.0
The comprehensiveness of the online pharmacies' privacy policies was
determined by investigating 49 possible characteristics. Table 32 shows the total number
of characteristics compiled for each of the pharmacies. None of the pharmacies' privacy
policies included all possible characteristics. The top three pharmacies that contained the
majority of options were: (a) Mediplan Health (n=30), (b) PeopleRx (n=29), and (c)
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Canada Drugs (n=23). The Web sites with the least comprehensive privacy policies
include: (a) Best Canadian Pharmacy (n=3), (b) DirectDrugmart (n=4), (c) Meds 4 Less
(n=4), and (d) SuperSaveRx (n=4). It is interesting to note that the last three
aforementioned pharmacies do not have a privacy policy on their Web site; however,
each requires consumers to provide medical history and prescriptions.
Table 32. Pharmacy Review - Number of
Characteristics per Pharmacy
Pharmacy Number
Abconlinepharmacy.com 7
Best Canadian Pharmacy 3
Canada Drugs 23
Canada Online Healthlink 7
Canadian Med Service 17
Canadian Pharmacy Network 22
Canadian Prescription Savers 5
CanadianMeds.com 19
CrossBorderPharmacy.com 18
DirectDrugmart 4
Discount Canadian Prescriptions 9
Discount Rx Mart 5
Doctorsolve Healthcare 14
MedCenter Canada 5
Mediplan Health 30
Meds 4 Less 4
Medsforall.com 6
PeopleRx 29
Rxbyfax 5
RxCounter.com 19
Smart Med Pharmacy 7
SuperSaveRx 4
The Canadian Drugstore 7
United Prescription Service 21
Universal Drugstore 22
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Summary of Results
This chapter reviewed the findings of an in-depth analysis of the privacy policies
and procedures of 25 major online Canadian pharmacies, as well as the purchasing
patterns and viewpoints of 147 consumers. The data has been presented in textual form
and supported with tabulated data.
The vast majority of 147 survey respondents strongly agreed or agreed that
privacy policy factors were important reasons when considering whether to use online
Canadian pharmacy Web sites. These characteristics included displays of privacy policies
on the site, licensing, security, opt-in ability, seal programs, and other factors. Some of
the characteristics garnered more weight than others, but overall the inclusion of most
privacy factors was important to consumers. However, consumer desire for privacy was
sometimes mitigated by other concerns, such as cost and legal issues.
Consumers’ desires for comprehensive privacy factors on Canadian sites did not
correlate to actual practices of 25 major online Canadian pharmacies. For example, the
ability to modify or delete consumer information, along with opt-in and opt-out
capability, was desired by most respondents. However, few of the pharmacy Web sites in
this study indicate that they allow customers to delete information from their databases or
their archived backup databases; however, a higher percentage of Web sites display
policies that inform consumers they can update or amend their personal information. The
analysis shows an incongruity between consumers’ desires for privacy factors on
Canadian Web sites versus the actual privacy practices of these pharmacy sites. The
results of this study leads to the next chapter, which contains the conclusion, implications
and recommendations for future research on this subject.
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Chapter 5
Conclusions, Implications, Recommendations and Summary
This chapter discusses the outcomes of the research, discusses implications of the
findings, and presents recommendations regarding how this research can advance
knowledge relating to the issues of consumer privacy in the online arena, especially
related to Canadian online pharmacies. A summary concludes the chapter.
Conclusions
The four goals and research questions of this study were met. These included the
following:
1. What types of privacy issues do Canadian online pharmacies address?
2. Do gaps exist in privacy protection provided to consumers of online Canadian
pharmacies?
3. Which online pharmacies offer the most comprehensive privacy policies and
what are their strengths and weaknesses?
4. What privacy and non-privacy criteria do consumers use when deciding to
order from these sites, and what factors do non-buyers cite for not purchasing
drugs?
The first goal was to identify the types of privacy issues being addressed by
Canadian online pharmacies’ policies. To answer this question, a framework of analysis
was used to compile privacy issue characteristics. The literature review, prior research
studies, and best-practices of the online pharmacy industry helped in the compilation of
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privacy characteristics to be included in both the online user survey and the review of 25
online pharmacies.
A second goal of this study was to determine the gaps in privacy protection for
consumers of online pharmacies. Results showed that most Canadian online pharmacies
do incorporate some measure of privacy policies into their Web sites; however, the
survey of 25 of these sites showed that most sites did not adhere to best-practices
guidelines for effective privacy policies. Further, some sites were found to be more
stringent and comprehensive in their policies than others. The Research Question 2 was
answered by showing that there are significant gaps in privacy protection for consumers
among these types of Web sites.
The third research goal was to review which online pharmacies are the most
effective (defined in chapter one as addressing a variety of privacy policies), and to
analyze their strengths and weaknesses. Mediplan Health, PeopleRx and Canada Drugs
were found to have the most comprehensive privacy policies. The results of the consumer
survey confirmed that online pharmacies with the most effective privacy policies were
those that assured their customers and potential customers that they had adequate security
features in place and that consumers and potential consumers would be provided with the
opportunity to revise, change, or otherwise alter their information if they required or
desired to do so, as well as opt-out. Clearly, the criteria consumers use when deciding to
order from these sites include wanting some control over how their personal information
would be used, and who would have access to it in the future.
The fourth goal of the study was to determine the criteria consumers used when
deciding whether to order from a site, what privacy issues were important to them, and
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what reasons were given by non-users for not utilizing the sites. This portion of the study
involved an online survey of consumers who utilize medical Web sites, and therefore
were more likely to use online pharmacies for their pharmaceutical purchases. A
percentage of medical Web site users had used Canadian pharmacies and contributed
first-hand knowledge of their views and concerns about using online pharmacy sites.
Because many Americans use online Canadian pharmacies to take advantage of the lower
cost of prescription drugs, it was conceivable that the research would indicate that
although these consumers are worried about their privacy, they would prove to be more
concerned with the price and availability of the products. The results of the online survey
showed that online consumers are concerned with privacy issues, although some privacy
policy characteristics, such as security and ability to opt-out, are more highly valued than
others, such as COPPA warnings. Those consumers who did not use a Canadian online
pharmacy also indicated that privacy was important; however, certain guidelines related
to privacy were found to be more important than others.
While the consumer survey showed respondents had a positive view towards
comprehensive privacy policies, when consumers were faced with the choice between
purchasing lower-cost pharmaceuticals or choosing a site with strong privacy policy
guidelines, they often placed higher value on low cost. This is consistent with existing
research showing that consumers recognize the trade-offs between privacy and economic
benefits they enjoy with online purchasing (U.S. Federal Trade Commission, 2004).
Another important conclusion related to the question of how many sites adhere to
their own policies, and which aspects of privacy issues are included on a privacy page.
One of the guiding tenets of this study was that an online pharmacy site that scored well
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on the statistics gathered in the study could be regarded as being highly effective in
promoting customer privacy and adhering to privacy laws and guidelines. The results of
the survey of the 25 online Canadian pharmacies showed that most of the sites provided a
privacy link on their home page, most required a health profile and an original or copy of
a prescription, and a majority featured their license number on their site. However,
beyond these commonalities, there existed vast differences in the manner in which these
services were administered and the security and privacy provisions that were used. This
lack of policy consistency can result in consumer confusion about drug information, and
the potential for third-party providers to obtain sensitive information about the
consumers.
Implications
This study has implications for online consumers as well as Canadian pharmacies
and their customers. The primary benefit for consumers is a methodology for reviewing a
variety of factors and best-practices related to online privacy practices. It is imperative to
realize that because of the myriad of U.S. and Canadian laws, as well as self-regulation
approaches to privacy, consumers may not have a thorough understanding of how their
online privacy is protected and what features they should review in a comprehensive
privacy policy. In addition, there is no overall Web site comparison of the privacy
policies for online Canadian pharmacies. Although this study is not meant to be a study
of all sites, its results provide an understanding of best-practice policy features that
consumers can review on e-commerce sites, and affords a review of 25 major Canadian
pharmacy sites.
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Using online pharmacy firms involves both risks as well as the benefits that
online shopping can bring to bear on modern healthcare practices. Unfortunately, the
research showed that, in some cases, online pharmacies operate outside of accepted
pharmaceutical and best-practice privacy practice guidelines. Notwithstanding the
dangers typically associated with these online pharmacy providers, the high costs of
prescription medications in the United States has compelled many consumers to seek
alternatives through these online outlets.
Therefore, it is clear that consumers should be cautious of online pharmacies as a
means of obtaining products as well as cautious of practices online that are illegal in an
offline environment. For instance, in some cases, online pharmacies only require
customers to complete a modest questionnaire before ordering prescription drugs.
Although this reduces the amount of private information held by the site, it also bypasses
any personal evaluation by a healthcare professional, a situation that may be detrimental
to the consumer’s health. Following the recommendations of Cadogan (2001), consumers
need comprehensive and accurate information to protect their privacy; it is recommended
that consumers familiarize themselves with both the security and privacy issues involved
in such online transactions, and investigate a potential online pharmacy by checking the
online sites for privacy policy guidelines or any potential consumer feedback.
In addition to implications for consumers, the study has consequences for Web
pharmacies and offers practical applications for their improvement. If these firms choose
to implement stricter privacy polices than those used currently, they can develop their
overall policy based on best-practice elements contained in this study. This model may be
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helpful for those pharmacies seeking to capture additional market share among U.S.
consumers who place a value on more comprehensive privacy concerns.
A heightened awareness of consumers’ attitudes toward privacy could serve as a
means for pharmacies to develop more comprehensive privacy pages based on
consumers’ attitudes and desires. The opportunity for firms to evaluate which privacy
features are most important to their shoppers will allow them to tailor their online privacy
policies. For example, an online firm can use the methodology and survey instruments
developed in this paper to analyze the behaviors and desires of its own customers. If its
customers have an overriding desire for tighter privacy controls, it may be advantageous
for the site to incorporate the best-practice privacy features described in this study.
Alternatively, if a firm discovers that the low cost of the pharmaceuticals overrides
privacy concerns, it may make a business decision not to spend time being concerned
about the nature of its privacy policy.
Recommendations
Because of the ever-changing information in Web sites, it is highly probable that
the privacy features listed in the 25 reviewed Canadian pharmacy sites may become
outdated with the passage of time. Thus, follow-up studies of these sites and a
comparison of pre- and post- results would indicate the levels of privacy changes among
sites, especially in relation to simultaneous modification to laws, regulations, and
political changes.
Hundreds of Canadian mail-order pharmacies now exist on the Internet; this study
was limited to 25 sites. It is recommended that analysis of other sites be undertaken, as
115
such studies may indicate whether the findings of this study are representative of other
online pharmacies.
Further research also is needed in the area of consumer attitudes towards privacy
policies among online Canadian pharmacies. This study was limited to 147 respondents
who utilized at least one of several online medical Web sites. It is plausible that privacy
priorities may be different among consumers who utilize other types of Web sites.
Further research studies should involve surveying respondents who use other Web sites
and whose demographic characteristics are representative of all users.
Results of this study showed considerable variation in the comprehensiveness of
Canadian online pharmacy privacy policies. However, a statement of policy is not the
same as effective implementation, nor is it necessarily the case that privacy policies,
whether comprehensive or not, are effective in preventing the compromise of personal
information. Thus, it is recommended that further research in the effectiveness of such
policies needs to be undertaken, in the hope of determining whether more stringent
policies result in fewer compromises of personal information.
Conclusion
Although most of the 25 Canadian online pharmacies examined in this study have
some elements of a privacy policy, their level of comprehensiveness is inconsistent. In
addition, it was found that although consumers value stringent and comprehensive
policies, other factors, such as cost and availability, play a key role in determining
whether consumers use a site. Such choices should not have to be made in an area as
critical as needed medications. Canadian online pharmacy Web sites should provide a
more consistent level of privacy protection than currently offered.
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Appendix A
Canadian Online Pharmacies Chosen for Evaluation
Abconlinepharmacy.com http://www.abconlinepharmacy.com
Best Canadian Pharmacy http://www.best-canadian-pharmacy.com
Canada Drugs http://www.canadadrugs.com
Canada Online Healthlink http://www.candrugstore.com
Canadian Med Service http://www.canadianmedservice.com
Canadian Pharmacy Network http://www.canadianpharmacynetwork.com
Canadian Prescription Savers http://www.canadianprescriptionsavers.com
CanadianMeds.com http://www.canadianmeds.com
CrossBorderPharmacy.com http://www.crossborderpharmacy.com
DirectDrugmart http://www.directdrugmart.com
Discount Canadian Prescriptions http://www.dcpdrugs.com
Discount Rx Mart http://www.discountrxmart.com
Doctorsolve Healthcare http://www.doctorsolve.com
MedCenter Canada http://www.medcentercanada.com
Mediplan Health http://www.rxnorth.com
Meds 4 Less http://www.apromedica.com
Medsforall.com http://www.medsforall.com
PeopleRx http://www.peoplerx.com
Rxbyfax http://www.rxbyfax.com
RxCounter.com http://www.rx-counter.com
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Smart Med Pharmacy http://www.smartmed.ca
SuperSaveRx http://www.supersaverx.com
The Canadian Drugstore http://www.thecanadiandrugstore.com
United Prescription Service http://www.smartchoicepharmacy.com
Universal Drugstore http://www.universaldrugstore.com
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Appendix B
Spreadsheet of Privacy Policy Information for Canadian Online Pharmacies
Table 33. Spreadsheet of Privacy Policy Information for Canadian Online
Pharmacies
ABC Best CanDrugs Candrugst Canmedsvc
General
Info on
Site
Overall
privacy policy
privacy link on
home page
X X X
privacy link on
non-home page
X X
no privacy
policy
Privacy seal
use
BBBOnLine X
TRUSTe
CIPA seal X X
VIPPS
Licensing
License
number on site
X X X
Actual
Pharmacy
X X X
Offers
prescriptions
through
affiliate
X X
Medical
information
requires health
profile
X X X X
requires
original or
copy of
prescription
X X X X
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Table 33. (Continued)
ABC Best CanDrugs Candrugst Canmedsvc
Info
contained
within
privacy
policy
Demographic
information
email X
social security
address X
telephone X
credit card X
demographics
(gender, age) X
Use of cookies
Uses cookies X
Third-party can
place cookies
Computer
software and
hardware
information
collected from
cookies
IP address
browser types
referring web
site address
log files
usage tracking
domain name
Opt-in and
opt-out
Opt-in ability
Opt-out ability X
Personal
update of
information in
system
Can delete
information
X
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Table 33. (Continued)
ABC Best CanDrugs Candrugst Canmedsvc
Can delete
from archived
database
Can update /
amend data in
database
X X
Disclosure of
information to
third parties
and affiliates
does not share
with third
parties
X X X X
discloses data
to third parties
if you consent X
if required to
perform
services
X X
if legally
required X X
if company
acquires firm
or merges
X X
discloses data
to affiliates
X X X
Steps to
provide
security
SSL and/or
encryption
X
Only allow
specific
personnel
access to data
X X
Password login
system
Credit cards
handled by
third party
Firewalls X
121
Table 33. (Continued)
ABC Best CanDrugs Candrugst Canmedsvc
Servers/data
kept in
protected
environment
X
Absolving data
collection
Absolves
outside links
Absolves
data collected
by others
Does not
collect data
about children
under 13
Will post
changes to
privacy policy
X X
Provides email
or phone
contact on
privacy page
X X
Can
pharmnet
Can
prescr Canmeds
Cross
bord
Direct
drug
General
Info on
Site
Overall
privacy policy
privacy link
on home page X X X
privacy link
on non-home
page
no privacy
policy X X
Privacy seal
use
BBBOnLine
TRUSTe
CIPA seal X
VIPPS
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Table 33. (Continued)
Can
pharmnet
Can
prescr Canmeds
Cross
bord
Direct
drug
Licensing
License
number on
site
X X X
Actual
Pharmacy X
Offers
prescriptions
through
affiliate
X X X X
Medical
information
requires
health profile
X X X X X
requires
original or
copy of
prescription
X X X X X
Info
contained
within
privacy
policy
Demographic
information
email
X X X
social
security
address
X X X
telephone X X X
credit card X X X
demographics
(gender, age) X X X
Use of cookies
Uses cookies
X X
Third-party
can place
cookies
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Table 33. (Continued)
Can
pharmnet
Can
prescr Canmeds
Cross
bord
Direct
drug
Computer
software and
hardware
information
collected from
cookies
IP address X X
browser types
referring web
site address
log files
usage
tracking X X
domain name X
Opt-in and opt-
out
Opt-in ability
Opt-out
ability
Personal
update of
information in
system
Can delete
information
Can delete
from
archived
database
Can update /
amend data
in database X X X
Disclosure of
information to
third parties
and affiliates
does not
share with
third parties
discloses data
to third
parties
if you
consent X
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Table 33. (Continued)
Can
pharmnet
Can
prescr Canmeds
Cross
bord
Direct
drug
if required to
perform
services
if legally
required X X X
if company
acquires firm
or merges
X X X
discloses data
to affiliates
X
Steps to
provide
security
SSL and/or
encryption
Only allow
specific
personnel
access to data
Password
login system
Credit cards
handled by
third party
Firewalls
Servers/data
kept in
protected
environment
Absolving data
collection
Absolves
outside links
X X X
Absolves
data collected
by others
X X
Does not
collect data
about children
under 13
X X X
Will post
changes to
privacy policy
X X X
Provides email
or phone
contact on
privacy page
X X X
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Table 33. (Continued)
Dcpdrugs Discrx Doctorsolv
Med
center Rxnorth
General
Info on
Site
Overall
privacy policy
privacy link
on home page X X X X
privacy link
on non-home
page
no privacy
policy X
Privacy seal
use
BBBOnLine X
TRUSTe
CIPA seal X X
VIPPS
Licensing
License
number on
site
X X X X
Actual
Pharmacy X X
Offers
prescriptions
through
affiliate
X X X
Medical
information
requires
health profile X X X X X
requires
original or
copy of
prescription
X X X X X
Info
contained
within
privacy
policy
Demographic
information
email X
social
security
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Table 33. (Continued)
Dcpdrugs Discrx Doctorsolv
Med
center Rxnorth
address X X
telephone X X
credit card X X
demographics
(gender, age) X
Use of cookies
Uses cookies X
Third-party
can place
cookies
Computer
software and
hardware
information
collected from
cookies
IP address X
browser types X
referring web
site address X
log files
usage
tracking X
domain name X
Opt-in and
opt-out
Opt-in ability
Opt-out
ability X X
Personal
update of
information in
system
Can delete
information
Can delete
from
archived
database
Can update /
amend data
in database
X
Disclosure of
information to
third parties
and affiliates
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Table 33. (Continued)
Dcpdrugs Discrx Doctorsolv
Med
center Rxnorth
does not
share with
third parties
X X X
discloses data
to third
parties
if you
consent X
if required to
perform
services
X X
if legally
required X X
if company
acquires firm
or merges
X
discloses data
to affiliates X
Steps to
provide
security
SSL and/or
encryption X X
Only allow
specific
personnel
access to data
X
Password
login system
Credit cards
handled by
third party
Firewalls
Servers/data
kept in
protected
environment
X
Absolving
data collection
Absolves
outside links
Absolves
data collected
by others
X
Does not
collect data
about children
under 13
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Table 33. (Continued)
Dcpdrugs Discrx Doctorsolv
Med
center Rxnorth
Will post
changes to
privacy policy
X
Provides email
or phone
contact on
privacy page
X X X
Apromed
Meds
forall Peoplerx Rxbyfax
Rx
counter
General
Info on
Site
Overall
privacy policy
privacy link
on home page X X X
privacy link
on non-home
page
no privacy
policy X X
Privacy seal
use
BBBOnLine
TRUSTe X
CIPA seal
VIPPS
Licensing
License
number on
site
X X X
Actual
Pharmacy X
Offers
prescriptions
through
affiliate
X X X X
Medical
information
requires
health profile X X X X X
requires
original or
copy of
prescription
X X X X X
Info
contained
within
privacy
policy
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Table 33. (Continued)
Apromed
Meds
forall Peoplerx Rxbyfax
Rx
counter
Demographic
information
email X
social
security
address X
telephone X
credit card X
demographics
(gender, age) X
Use of cookies
Uses cookies X
Third-party
can place
cookies
Computer
software and
hardware
information
collected from
cookies
IP address X X
browser types X
referring web
site address
log files X
usage
tracking X X
domain name
Opt-in and
opt-out
Opt-in ability
Opt-out
ability X
Personal
update of
information in
system
Can delete
information X
Can delete
from
archived
database
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Table 33. (Continued)
Apromed
Meds
forall Peoplerx Rxbyfax
Rx
counter
Can update /
amend data
in database
X X
Disclosure of
information to
third parties
and affiliates
does not
share with
third parties
X
discloses data
to third
parties
X X
if you
consent X X
if required to
perform
services
X X
if legally
required X X
if company
acquires firm
or merges
X
discloses data
to affiliates X
Steps to
provide
security
SSL and/or
encryption X X
Only allow
specific
personnel
access to data
X
Password
login system X X
Credit cards
handled by
third party
Firewalls X
Servers/data
kept in
protected
environment
X X
Absolving
data collection
Absolves
outside links
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Table 33. (Continued)
Apromed
Meds
forall Peoplerx Rxbyfax
Rx
counter
Absolves
data collected
by others
Does not
collect data
about children
under 13
Will post
changes to
privacy policy
X X
Provides email
or phone
contact on
privacy page
X X
Smartmed
Super
save
The
Canada
Smart
choice Universal
General
Info on
Site
Overall
privacy policy
privacy link
on home
page
X X X
privacy link
on non-home
page
X
no privacy
policy X
Privacy seal
use
BBBOnLine X
TRUSTe
CIPA seal X X
VIPPS
Licensing
License
number on
site
X X X X
Actual
Pharmacy X X X X
Offers
prescriptions
through
affiliate
X
Medical
information
requires
health profile X X X X X
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Table 33. (Continued)
Smartmed
Super
save
The
Canada
Smart
choice Universal
requires
original or
copy of
prescription
X X X X X
Info
contained
within
privacy
policy
Demographic
information
email X X
social
security
address X X
telephone X X
credit card X X
demographics
(gender, age) X
Use of cookies
Uses cookies X
Third-party
can place
cookies
Computer
software and
hardware
information
collected from
cookies
IP address X
browser types
referring web
site address
log files
usage
tracking X
domain name
Opt-in and
opt-out
Opt-in ability
Opt-out
ability
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Table 33. (Continued)
Smartmed
Super
save
The
Canada
Smart
choice Universal
Personal
update of
information in
system
Can delete
information
Can delete
from
archived
database
Can update /
amend data
in database
X X
Disclosure of
information to
third parties
and affiliates
does not
share with
third parties
X X X X
discloses data
to third
parties
if you
consent X
if required to
perform
services
X
if legally
required X X
if company
acquires firm
or merges
X
discloses data
to affiliates
Steps to
provide
security
SSL and/or
encryption X
Only allow
specific
personnel
access to data
X
Password
login system X
Credit cards
handled by
third party
Firewalls X
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Table 33. (Continued)
Smartmed
Super
save
The
Canada
Smart
choice Universal
Servers/data
kept in
protected
environment
X
Absolving
data collection
Absolves
outside links
Absolves
data collected
by others
X
Does not
collect data
about children
under 13
Will post
changes to
privacy policy
X X
Provides email
or phone
contact on
privacy page
X X X
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Appendix C
Online Survey Questions
This survey will be tabulated and analyzed by a research group to determine
consumer's views of Canadian online pharmacies and to evaluate how their privacy
policies can be used to better serve their purchasing needs.
*Please note-Your individual answers will be anonymous and completely confidential. It
is your opinion that is important. Individual answers will not be available to anyone
outside the research institution conducting this survey. Your answers will be combined
with the answers from other respondents for a composite picture of consumer’s attitudes
towards Canadian online pharmacies and their privacy policies.
The survey consists of 45 questions and should take approximately 10-15 minutes to
complete.
Demographics.
1. What is your gender?
a. Male
b. Female
2. What is your age?
a. Under 40
b. 41 – 60
c. Over 60
3. Do you have a prescription insurance plan that pays for some or all of your
prescriptions?
a. Yes
b. No
4. Have you used an online Canadian Pharmacy to order your prescriptions
within the past year?
a. Yes
b. No
5. If you have used an online Canadian pharmacy within the past year, what
were the main reasons you chose to use it? Please choose all that apply
a. Cost savings
b. Privacy policy on site
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c. Convenience
d. Availability of products
e. Other/None of the above
6. If you have not used an online Canadian pharmacy within the past year, what
were the main reasons you chose not to use it? Please check all that apply
a. Legal issues with importing drugs from Canada
b. Don't trust online purchasing
c. Concerned about privacy and personal medical data
d. Concerned about the quality of drugs from Canada
e. Other/None of the above
Overall Privacy. (on a scale from 1 to 5)
7. I am more likely to use an online Canadian pharmacy if a link to the
privacy policy is somewhere on the home page.
8. I am more likely to use an online Canadian pharmacy if there is not a link
to the privacy policy somewhere on the home page.
9. I am likely to use an online Canadian pharmacy if there is not a posted
privacy policy.
10. I am likely to use an online Canadian pharmacy if the site uses a privacy
seal (such as Better Business Bureau Online).
Consumer/Licensing. (on a scale from 1 to 5)
11. I am more likely to use an online Canadian pharmacy if there is a
pharmacy license prominently displayed on the site.
12. I am more likely to use an online Canadian pharmacy site if I am informed
that this firm is an actual registered pharmacy as opposed to a pharmacy
intermediary (affiliated middleman pharmacy).
13. I am more likely to use an online Canadian pharmacy if the site requires
me to fill out a health profile before I can place an order.
14. I am more likely to use an online Canadian pharmacy if the site requires
an original or copy of the prescription.
Personal Demographic. (on a scale from 1 to 5)
15. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it collects my email address.
16. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it collects my mailing address.
17. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it collects my telephone number.
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18. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it collects my credit card number.
19. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it collects demographic information about me (age, gender, etc).
Computer Hardware/Software and Cookies Information. (on a scale from 1
to 5)
20. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it uses cookies.
21. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it uses cookies to track your computer's IP address.
22. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it uses cookies to collect usage tracking data.
23. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it uses cookies to collect domain name information.
Opt-In and Alter Ability. (on a scale from 1 to 5)
24. I am more likely to use an online Canadian pharmacy if the privacy policy
states that the consumer can delete stored personal information from the
site's database.
25. I am more likely to use an online Canadian pharmacy if the privacy policy
states that the consumer can ALTER personal information from the site's
database.
26. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it allows you to opt-out of their information collection process.
27. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it will not collect any information about you unless you give
opt-in permission for this collection.
Disclosure of Information to Third Parties and Affiliates. (on a scale from 1
to 5)
28. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it does not disclose data to third parties.
29. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it discloses data to third parties.
30. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it only discloses information to outside parties if you consent to
the release.
31. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it releases information to third parties in order to perform
services for them.
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32. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it releases information to third parties if legally required to do
so.
33. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it releases information to third parties if the firm was acquired
or merged.
34. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it releases information to associated affiliate firms.
35. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it absolves outside URL links from liability.
36. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it is not responsible for data that is collected by third-parties.
Security. (on a scale from 1 to 5)
37. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it provides SSL/encryption security
38. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it only allows specific employees to access personal customer
information.
39. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it has a password/login system for its customers.
40. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it protects the data with a firewall.
41. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it keeps its database/servers in a protected physical
environment.
Miscellaneous Information. (on a scale from 1 to 5)
42. I am more likely to use an online Canadian pharmacy if the privacy policy
states that it adheres to the COPPA law (does not collect information
about children under 13 without the parents’ permission).
43. I am more likely to use an online Canadian pharmacy if the privacy policy
states that will post any changes to its privacy policy.
44. I am more likely to use an online Canadian pharmacy if there is an email
or phone contact on the privacy policy page.
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Appendix D
Screen Print of Online Advertisement in Healthcentral.com Web Site
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